Pneumonias (Asthma/COPD co-morbidities)

PNEUMONIA

pneumonia: An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, caused by an infection in one or both of the lungs (by bacteria, viruses, fungi, or mycoplasma.). Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints VIRALPNEUMOKNOWN VIRALPNEUMONAS MYCOBLUNGATYPICA J10_PNEUMONAS PNEUMOBACTKNOWN	80733
6. Filter based on genotype QC (FinnGen only)	80733

Control definitions (FinnGen only)

Control exclude: IBD_CMV

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	PNEUMONIA
CONTROL_EXCLUDE	IBD_CMV
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	VIRALPNEUMOKNOWN\|VIRALPNEUMONAS\|MYCOBLUNGATYPICA\|J10_PNEUMONAS\|PNEUMOBACTKNOWN
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pneumonias (Asthma/COPD co-morbidities) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	80733	34347	46386
Unadjusted period prevalence (%)	16.73	11.71	20.45
Median age at first event (years)	63.20	57.64	67.31

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
36396: Matched controls
290965

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H02AB07

ATC

prednisone; oral

2.1

323.0

4630

18947

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

323.0

8923

45330

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

323.0

3054

10172

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.0

323.0

2264

4778

C07AB07

ATC

bisoprolol; oral

1.8

323.0

12157

63827

JN4BD

NOMESCO Finland

Extensive body CT

2.8

323.0

3364

10344

Z2446

NOMESCO Finland

Social worker

2.6

323.0

2641

8395

J45.1

ICD-10 Finland

Nonallergic asthma

3.0

323.0

2811

7883

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

83.7

323.0

516

A02BC02

ATC

pantoprazole; systemic

1.7

323.0

21126

131546

N05AH04

ATC

quetiapine; oral

1.9

323.0

6252

28663

B01AA03

ATC

warfarin; systemic

2.4

323.0

3596

12632

J01DB01

ATC

cefalexin; oral

1.7

323.0

28973

202155

J01CA04

ATC

amoxicillin; systemic

1.7

323.0

29576

207738

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.1

323.0

4506

9667

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

+∞

323.0

2517

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

323.0

5677

24841

J45.9

ICD-10 Finland

Asthma, unspecified

2.7

323.0

7414

24958

A28

ICPC

Limited function/disability NOS

3.0

323.0

3410

9590

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

48.2

323.0

739

125

A06AD11

ATC

lactulose; oral

2.5

323.0

3549

12180

N02AX02

ATC

tramadol; systemic, rectal

1.8

323.0

13481

73174

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.7

323.0

3053

5512

AA1AD

NOMESCO Finland

CT of head and brain

2.1

323.0

6716

28060

A46

ICD-10 Finland

Erysipelas

2.5

323.0

4021

13950

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.7

323.0

3741

11692

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

10.5

323.0

1432

1135

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

323.0

7629

28074

GD1AD

NOMESCO Finland

Thorax CT examination

4.6

323.0

1594

2895

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

131.5

323.0

8338

656

Z3226

NOMESCO Finland

Physiotherapist

1.9

323.0

6150

27753

XF400

NOMESCO Finland

ECG with 12 standard connections

2.7

323.0

5378

17732

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.7

323.0

7259

24441

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

5.1

323.0

1156

1861

48509

ICD-8 Finland

Bronchopneumonia, unspecified

+∞

323.0

1565

R50.9

ICD-10 Finland

Fever, unspecified

3.2

323.0

6235

17830

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.1

323.0

4236

7264

C03CA01

ATC

furosemide; systemic

3.4

323.0

7350

20111

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.7

323.0

2405

4350

A41.9

ICD-10 Finland

Sepsis, unspecified

6.6

323.0

1304

1630

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.9

323.0

2138

3692

WX892

NOMESCO Finland

Monitored bed care

3.2

323.0

2642

6886

TGC00

NOMESCO Finland

Bronchial lavation

9.3

323.0

1271

1129

I50.0

ICD-10 Finland

Congestive heart failure

5.9

323.0

1131

1566

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

9.1

323.0

874

786

TPH07

NOMESCO Finland

Cathetrisation of artery

2.8

323.0

3198

9591

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.1

323.0

2114

5650

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.4

323.0

4834

17154

R03BB04

ATC

tiotropium bromide; inhalant

4.5

323.0

3444

6664

J47

ICD-10 Finland

Bronchiectasis

10.0

323.0

720

586

J01MA12

ATC

levofloxacin; systemic

4.0

323.0

8193

19786

R06.0

ICD-10 Finland

Dyspnoea

2.3

323.0

8303

32783

H02AB06

ATC

prednisolone; systemic

2.2

323.0

17216

84621

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.3

323.0

1874

4663

J46

ICD-10 Finland

Status asthmaticus

5.1

323.0

1280

2070

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.5

323.0

3161

10769

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

338.4

323.0

668

ZXD05

NOMESCO Finland

Urgent procedure

1.8

323.0

10349

53599

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

323.0

19404

114885

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

5.5

323.0

2176

3313

N02AA05

ATC

oxycodone; systemic

3.0

323.0

4306

12341

N05BA01

ATC

diazepam; systemic, rectal

2.2

323.0

4630

18308

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.3

323.0

4674

17403

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.3

323.0

3367

6763

R03AC02

ATC

salbutamol; inhalant

1.9

323.0

20047

113215

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.5

323.0

7627

28186

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

323.0

9666

47085

48609

ICD-8 Finland

Pneumonia, unspecified

+∞

323.0

2275

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.7

323.0

1627

3666

SPAT1255

SPAT

Intravenous administration of medicine

2.9

323.0

2161

6111

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.6

323.0

5087

17310

R03DA04

ATC

theophylline; systemic, rectal

4.1

323.0

1490

2976

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

4.3

323.0

3344

6651

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

7.0

323.0

1066

1255

ZX120

NOMESCO Finland

Intravenous

2.7

323.0

3367

10736

N05CD07

ATC

temazepam; oral

2.5

323.0

3380

11634

Z3231

NOMESCO Finland

Registered nurse

1.8

323.0

8950

44525

N05AA02

ATC

levomepromazine; systemic

3.8

323.0

1842

4062

R03BA05

ATC

fluticasone; inhalant

1.9

323.0

6617

30830

J18.9

ICD-10 Finland

Pneumonia, unspecified

102.4

323.0

24942

6044

R81

ICPC

Pneumonia

11.8

323.0

2037

1455

R4110

NOMESCO Finland

Physiotherapy

1.9

323.0

8807

42448

J01MA14

ATC

moxifloxacin; systemic

6.7

323.0

5483

7471

J12.8

ICD-10 Finland

Other viral pneumonia

478.6

323.0

764

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.3

323.0

5999

12646

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.4

323.0

3730

13051

J01FF01

ATC

clindamycin; systemic

1.8

323.0

9371

46902

N03AX16

ATC

pregabalin; oral

1.8

323.0

7533

36964

I50.9

ICD-10 Finland

Heart failure, unspecified

5.0

323.0

2543

4269

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

323.0

5130

20189

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

5.3

323.0

2598

4142

N05CF01

ATC

zopiclone; oral

1.7

323.0

9587

49494

N02BE01

ATC

paracetamol; systemic, rectal

1.7

323.0

29251

204151

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

323.0

8710

42335

A03

ICPC

Fever

1.8

323.0

6392

30224

UGC12

NOMESCO Finland

Flexible bronchoscopy

5.9

323.0

3123

4559

WX872

NOMESCO Finland

Intensive care

3.8

323.0

1571

3450

J01FA06

ATC

roxithromycin; oral

1.9

323.0

14921

77194

R02

ICPC

Shortness of breath/dyspnoea

2.4

323.0

3974

13953

J01AA02

ATC

doxycycline; systemic

1.7

323.0

26400

178282

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.6

323.0

18034

61898

J96.1

ICD-10 Finland

Chronic respiratory failure

12.6

321.2

626

405

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.8

320.4

1533

3371

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

34.4

320.3

451

106

B01AB05

ATC

enoxaparin; parenteral

1.7

319.3

8592

44782

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.0

318.1

2103

5903

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

6.5

316.5

902

1132

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.6

316.5

2538

8033

J01MA02

ATC

ciprofloxacin; systemic

1.6

312.2

11153

62753

R03BA02

ATC

budesonide; inhalant

1.8

311.3

6142

29003

J15.8

ICD-10 Finland

Other bacterial pneumonia

56.4

309.2

397

N03AG01

ATC

valproic acid; systemic, rectal

2.6

308.2

2479

7857

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.9

305.2

5168

23104

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

304.1

3365

12599

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.2

301.3

1028

1617

D64.9

ICD-10 Finland

Anaemia, unspecified

2.7

295.6

2254

6916

TK800

NOMESCO Finland

Hemodialysis

6.0

294.9

887

1196

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

16.8

293.2

507

244

N05BA04

ATC

oxazepam; oral

1.7

292.7

8013

41788

L28

ICPC

Limited function/disability (L)

2.1

289.2

3779

15224

J86.9

ICD-10 Finland

Pyothorax without fistula

27.7

288.6

428

125

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

287.3

11153

63753

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

287.2

8339

44179

N05BA06

ATC

lorazepam; systemic, sublingual

3.2

284.6

1681

4355

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

283.8

16779

105590

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

282.4

5783

27546

R03DC03

ATC

montelukast; oral

1.8

282.1

5811

27730

Z51.5

ICD-10 Finland

Palliative care

3.8

280.8

1332

2903

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.3

280.5

1147

2183

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

29.5

280.3

409

112

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

279.8

6693

33476

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

279.7

6521

32359

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

278.9

6482

32132

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

276.4

13717

82867

ZXE20

NOMESCO Finland

More than three and less than five hours

2.0

275.9

3992

16751

R96

ICPC

Asthma

2.3

273.8

2922

10727

127

Kela drug reimbursment

Transplant complication

6.4

273.1

791

1014

L04AA06

ATC

mycophenolic acid; systemic

5.6

272.3

870

1265

C08CA01

ATC

amlodipine; oral

1.6

272.2

8112

43175

SPAT1254

SPAT

Administration of medicine

2.0

271.2

4261

18452

M04AA01

ATC

allopurinol; systemic

2.5

268.3

2402

8062

R05

ICPC

Cough

1.7

265.5

7341

38225

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

6.0

265.4

799

1078

TKC20

NOMESCO Finland

Catheterisation of bladder

3.0

264.7

1740

4850

48099

ICD-8 Finland

Viral pneumonia

+∞

263.7

276

N05AH03

ATC

olanzapine; systemic

2.4

263.5

2498

8637

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

263.2

3301

13035

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

5.5

263.0

854

1266

R03AC12

ATC

salmeterol; inhalant

3.4

261.9

1429

3486

N06AX11

ATC

mirtazapine; oral

1.6

260.3

10213

58198

J96.0

ICD-10 Finland

Acute respiratory failure

15.8

259.7

460

236

N05AH02

ATC

clozapine; systemic

4.2

257.3

1085

2125

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.5

254.3

2253

7511

JN4AD

NOMESCO Finland

Body CT examination

2.6

253.0

2030

6400

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

252.1

2909

11058

C03DA01

ATC

spironolactone; oral

2.4

251.0

2422

8441

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

250.8

4163

18362

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.7

249.7

938

1637

H02AB04

ATC

methylprednisolone; systemic

1.9

248.0

4578

20965

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.4

245.9

978

1809

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.0

245.6

1616

4502

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.1

245.4

3314

13479

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

245.4

6253

31709

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.9

244.4

1097

2275

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.8

243.4

1133

2426

N06AB04

ATC

citalopram; systemic

1.6

242.8

6988

36659

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.9

241.8

740

1019

N05AX08

ATC

risperidone; systemic

2.4

241.1

2342

8187

WX882

NOMESCO Finland

High dependency care

4.2

239.9

1014

1989

S97

ICPC

Chronic ulcer skin

3.3

239.0

1358

3413

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

12.5

237.8

464

301

4829X

ICD-9 Finland

Other bacterial pneumonia, Bacterial pneumonia unspecified

+∞

234.0

245

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

234.0

3239

13295

ZXE00

NOMESCO Finland

One hour or less

1.5

233.6

12557

76343

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

4.8

231.3

840

1414

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

9.5

231.1

515

437

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.6

229.7

1923

6203

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

229.7

3737

16325

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

229.4

7236

38812

Z2221

NOMESCO Finland

Medical doctor

1.6

228.9

8859

49995

J01DA01

ATC

[U] cefalexin; systemic

1.4

228.9

20819

140272

J45

ICD-10 Finland

Asthma

2.0

223.4

3284

13794

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

222.8

1949

6440

R60.0

ICD-10 Finland

Localized oedema

2.1

222.7

2800

11028

WX002

NOMESCO Finland

Sedation and analgesia

1.7

222.0

5497

27546

J20

ICD-10 Finland

Acute bronchitis

2.0

220.4

3074

12642

XG410

NOMESCO Finland

Flow-volume spirometry

3.1

220.3

1360

3624

F20.9

ICD-10 Finland

Schizophrenia, unspecified

3.8

219.9

1024

2192

C09AA05

ATC

ramipril; oral

1.7

218.8

5043

24727

SPAT1262

SPAT

Handing over of treatment supplies

1.8

218.4

4656

22280

A10AE04

ATC

insulin glargine; parenteral

2.2

218.4

2598

9984

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.2

217.1

898

1725

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.5

212.6

1919

6444

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.2

212.5

719

1118

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.1

212.2

1283

3369

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.4

212.1

1143

2757

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.3

211.8

1197

2993

T90

ICPC

Diabetes non-insulin dependent

1.7

211.4

5301

26622

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

210.9

14687

93439

R95

ICPC

Chron obstructive pulmonary disease

5.6

210.7

671

971

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.1

210.2

2739

10940

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

7.4

210.0

547

602

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

+∞

209.2

219

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

209.1

2714

10821

WW500

NOMESCO Finland

Blood transfusion

3.2

209.0

1204

3052

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

208.6

10658

63705

WX730

NOMESCO Finland

Conventional respirator

6.1

206.4

611

806

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.1

206.3

1277

3408

N05AD01

ATC

haloperidol; systemic

3.8

205.7

956

2042

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

+∞

205.3

215

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.2

205.2

2235

8240

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

204.0

4566

22144

205

Kela drug reimbursment

Chronic hypertension

1.7

203.0

5171

26054

R03AC03

ATC

terbutaline; inhalant

1.7

202.4

4653

22748

SPAT1263

SPAT

Sampling

1.4

201.6

13304

83538

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

12.0

200.9

398

267

N07BB01

ATC

disulfiram; oral

2.5

200.4

1731

5671

A02BC01

ATC

omeprazole; systemic

1.5

200.3

7604

42479

J01FA09

ATC

clarithromycin; systemic

1.5

199.7

10812

65264

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

199.4

2147

7871

R03BA01

ATC

beclometasone; inhalant

1.8

197.8

4314

20736

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.3

197.5

2047

7365

J45.8

ICD-10 Finland

Mixed asthma

3.3

197.2

1104

2738

R53

ICD-10 Finland

Malaise and fatigue

1.6

197.0

5768

30176

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

6.4

195.4

561

710

A07AA02

ATC

nystatin; oral

2.4

194.2

1761

5921

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.5

193.2

989

2289

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

193.0

3475

15678

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

192.8

6162

32959

N05AF03

ATC

chlorprothixene; systemic

3.2

192.7

1137

2932

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

192.7

11485

70536

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

6.0

192.6

579

779

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

192.4

2101

7746

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

192.3

3179

13912

R11

ICD-10 Finland

Nausea and vomiting

2.1

190.9

2469

9817

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

3.3

190.0

1071

2671

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

189.8

13592

86357

R05

ICD-10 Finland

Cough

1.6

189.6

5713

30082

4809X

ICD-9 Finland

Viral pneumonia, unspecified

+∞

189.1

198

48601

ICD-8 Finland

More specifically, unspecified pneumonia and the pleural irritation caused by it

+∞

189.1

198

A10BA02

ATC

metformin; oral

1.6

188.9

6171

33168

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.9

188.8

1240

3441

WZC30

NOMESCO Finland

Teaching

1.8

188.7

3780

17668

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.9

187.9

861

1816

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.7

187.8

704

1225

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

186.2

6418

34941

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

185.8

4318

21132

130

Kela drug reimbursment

Malignant tumour

2.4

185.6

1799

6256

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

185.5

7710

43848

S18

ICPC

Laceration/cut

1.4

184.2

11627

72032

ZXA00

NOMESCO Finland

Right side

1.5

184.2

7074

39504

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.9

184.0

2937

12679

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.7

183.4

508

612

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.8

181.5

856

1851

H02AB02

ATC

dexamethasone; systemic

1.9

181.3

2942

12776

B03XA02

ATC

darbepoetin alfa; parenteral

5.6

181.2

573

822

N03AX12

ATC

gabapentin; oral

1.7

180.1

4508

22527

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

179.9

5834

31252

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

179.4

11936

74579

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.5

178.8

925

2159

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

177.9

4130

20182

A04AA01

ATC

ondansetron; systemic, rectal

2.2

177.5

2031

7645

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.2

177.5

2047

7732

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

177.2

11296

69976

WX110

NOMESCO Finland

Local anesthesy

1.4

177.0

23942

168949

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.8

176.8

1286

3807

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.4

176.7

1679

5778

N03AE01

ATC

clonazepam; systemic

2.3

176.7

1869

6783

M05BA04

ATC

alendronic acid; oral

2.3

176.3

1814

6496

ZXA05

NOMESCO Finland

Left side

1.5

176.2

6572

36396

N04AA02

ATC

biperiden; systemic

3.8

175.8

812

1724

48298

ICD-8 Finland

Other bacterial pneumonia, Other

+∞

175.7

184

N18.8

ICD-10 Finland

Other chronic renal failure

4.7

175.5

647

1106

J15.7

ICD-10 Finland

Pneumonia due to Mycoplasma pneumoniae

30.4

175.0

253

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.5

174.2

899

2094

XW000

NOMESCO Finland

Bone marrow biopsy

3.1

174.0

1079

2880

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

5.5

174.0

560

821

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

173.2

3673

17450

C01AA05

ATC

digoxin; systemic

3.4

173.0

929

2232

R03AK08

ATC

formoterol and beclometasone; inhalant

2.7

172.9

1308

3967

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

172.8

6534

36277

L04AX01

ATC

azathioprine; systemic

2.4

172.2

1602

5451

R03BB01

ATC

ipratropium bromide; inhalant

3.6

169.6

839

1888

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.2

169.1

983

2506

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

48.2

168.9

222

M79.6

ICD-10 Finland

Pain in limb

1.4

167.3

10728

66353

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.0

167.2

1075

2940

M05BX04

ATC

denosumab; parenteral

2.8

166.7

1180

3434

B01AC04

ATC

clopidogrel; oral

2.0

166.1

2499

10531

R03AC13

ATC

formoterol; inhalant

2.5

166.0

1485

4947

WW200

NOMESCO Finland

Immunization

3.1

165.5

1025

2733

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.6

164.7

1343

4253

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.7

164.6

616

1070

UJF32

NOMESCO Finland

Coloscopy

1.5

163.6

6525

36610

SPAT1229

SPAT

Assessment of need for aid

2.2

162.7

1751

6402

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

162.0

1825

6812

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

4.6

161.8

613

1078

WF049

NOMESCO Finland

Radiotherapy of metastasis

3.6

161.8

808

1832

WX722

NOMESCO Finland

PEEP

2.6

161.8

1271

3939

C10AA01

ATC

simvastatin; oral

1.4

161.6

8473

50351

G47.3

ICD-10 Finland

Sleep apnoea

1.5

160.7

6078

33674

K08.3

ICD-10 Finland

Retained dental root

2.1

159.9

1940

7486

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

159.5

3242

15170

N06AA09

ATC

amitriptyline; systemic

1.9

159.5

2819

12593

J01FA15

ATC

telithromycin; oral

1.8

159.2

3359

15906

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.7

158.9

1220

3730

R04.2

ICD-10 Finland

Haemoptysis

3.6

158.7

788

1778

49300

ICD-8 Finland

Asthma, bronchiale

3.6

158.1

785

1771

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.6

156.9

592

1037

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

3.0

156.3

1001

2728

A11CC03

ATC

alfacalcidol; systemic

4.0

156.3

688

1399

XG466

NOMESCO Finland

Sleep oxymetry

3.0

155.1

999

2733

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

155.0

3457

16643

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.0

155.0

2153

8788

N03AX09

ATC

lamotrigine; oral

2.1

154.6

1838

7026

N06AX16

ATC

venlafaxine; oral

1.6

152.3

4819

25542

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

228.6

152.0

170

C01DA14

ATC

isosorbide mononitrate; oral

2.2

151.9

1671

6165

207

Kela drug reimbursment

Chronic arrhythmias

2.0

151.9

2139

8775

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.9

151.5

540

890

L03AA02

ATC

filgrastim; parenteral

3.3

150.6

852

2128

Z94.0

ICD-10 Finland

Kidney transplant status

5.4

150.5

491

732

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.3

149.6

1599

5822

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.3

148.5

808

1960

AN1

Coronary angiography

2.1

148.2

1823

7070

48199

ICD-8 Finland

Pneumococcal pneumonia

+∞

147.0

154

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

5.8

146.5

449

620

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.4

146.1

1366

4654

201

Kela drug reimbursment

Chronic cardiac insufficiency

3.3

146.0

797

1938

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.9

145.7

985

2781

I50.1

ICD-10 Finland

Left ventricular failure

3.7

144.5

701

1552

R06.2

ICD-10 Finland

Wheezing

2.3

144.2

1413

4930

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

143.6

2242

9563

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.3

143.1

1474

5271

ZX108

NOMESCO Finland

Inhalation

8.0

142.7

351

354

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.4

140.8

1369

4758

B01AF02

ATC

apixaban; oral

2.2

140.7

1612

6057

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

139.4

7355

43543

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.4

139.3

754

1822

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.6

138.9

677

1504

H25.1

ICD-10 Finland

Senile nuclear cataract

1.7

138.8

3328

16336

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

4.5

138.5

531

946

J18

ICD-10 Finland

Pneumonia, organism unspecified

8.6

138.4

326

306

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.5

138.1

704

1623

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.2

137.9

1506

5534

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

137.6

2137

9093

L17

ICPC

Foot/toe symptom/complaint

1.4

136.9

6956

40853

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

5.5

136.5

437

637

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

7.6

135.5

343

362

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

7.2

134.7

354

396

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

134.5

2027

8525

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

134.1

1772

7076

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

133.3

9504

59339

ZXA10

NOMESCO Finland

Bilateral

1.5

133.2

4690

25434

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

6.4

132.7

381

483

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.9

132.7

359

419

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.4

131.9

1263

4352

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

131.8

1988

8364

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

131.7

1735

6919

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.9

131.4

585

1202

N06AB03

ATC

fluoxetine; oral

1.6

131.4

3930

20468

R06AE07

ATC

cetirizine; oral

1.3

131.4

14659

98174

N05AB03

ATC

perphenazine; systemic, rectal

2.4

131.0

1203

4058

N05BA02

ATC

chlordiazepoxide; systemic

3.2

130.8

754

1909

N05AX12

ATC

aripiprazole; systemic

2.2

130.3

1528

5798

L89

ICD-10 Finland

Decubitus ulcer and pressure area

6.6

130.2

365

448

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

4.0

129.6

565

1139

L04AD01

ATC

ciclosporin; systemic

3.3

129.1

715

1758

E86

ICD-10 Finland

Volume depletion

4.5

129.0

501

904

A12AA04

ATC

calcium carbonate; oral

4.7

128.9

477

819

EBA00

NOMESCO Finland

Extraction of tooth

1.4

128.9

10334

65709

R05FB02

ATC

cough suppressants and expectorants

1.4

128.5

10446

66567

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

127.9

1610

6297

N03AF01

ATC

carbamazepine; oral, rectal

2.2

127.8

1388

5084

V03AE01

ATC

polystyrene sulfonate; oral

6.8

127.1

349

416

H02AB09

ATC

hydrocortisone; systemic

3.0

127.0

823

2260

M10.9

ICD-10 Finland

Gout, unspecified

2.5

125.7

1070

3465

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.8

124.9

880

2549

N05AA01

ATC

chlorpromazine; systemic, rectal

3.9

124.9

561

1162

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.9

124.2

552

1133

W19

ICD-10 Finland

Unspecified fall

1.8

124.1

2501

11627

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.9

124.0

378

519

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

123.7

2776

13339

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

122.5

7836

47879

B01AB10

ATC

tinzaparin; parenteral

2.0

122.3

1761

7271

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.9

121.6

812

2275

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

11.2

121.6

248

178

E87.6

ICD-10 Finland

Hypokalaemia

2.9

121.6

807

2252

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

6.4

121.6

345

431

Z71.8

ICD-10 Finland

Other specified counselling

1.4

121.4

7424

44988

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.0

121.3

532

1079

N06AA12

ATC

doxepin; systemic

2.2

121.2

1412

5339

SPAT1216

SPAT

Assessment of functional ability

1.7

120.8

3053

15178

WX725

NOMESCO Finland

Noninvasive ventilation

2.2

120.7

1324

4871

A04

ICPC

Weakness/tiredness general

1.6

120.7

3395

17377

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

2.9

120.6

801

2236

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.1

120.5

1432

5461

N19

ICD-10 Finland

Unspecified kidney failure

3.8

120.4

551

1161

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.6

119.8

455

803

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

5.2

119.5

405

632

A02BC05

ATC

esomeprazole; systemic

1.3

119.5

11684

76397

4810A

ICD-9 Finland

Pneumococcal pneumonia[PNEUMONIA PNEUMOCOCCICA]

+∞

119.3

125

N18.0

ICD-10 Finland

End-stage renal disease

6.2

118.8

349

457

R33

ICD-10 Finland

Retention of urine

2.5

117.8

1041

3440

GBB00

NOMESCO Finland

Tracheostomy

6.1

117.8

347

456

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

117.4

2291

10536

A41.8

ICD-10 Finland

Other specified sepsis

5.2

117.1

393

606

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

116.2

2621

12605

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

116.1

4870

27388

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

116.0

2327

10796

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

115.8

8793

55208

R03AK11

ATC

formoterol and fluticasone; inhalant

2.8

115.6

822

2397

N30.0

ICD-10 Finland

Acute cystitis

1.6

115.6

3678

19414

J94.8

ICD-10 Finland

Other specified pleural conditions

5.6

115.1

363

520

137

Kela drug reimbursment

Uraemia requiring dialysis

6.2

114.9

336

437

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

4.0

114.9

495

988

R4190

NOMESCO Finland

Nutritional therapy

2.3

114.7

1146

4031

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.1

114.6

1409

5452

SPAT1301

SPAT

No procedures

1.4

114.4

8524

53337

A12BA01

ATC

potassium chloride; oral

3.2

114.3

646

1612

P72

ICPC

Schizophrenia

3.0

114.1

718

1933

P15

ICPC

Chronic alcohol abuse

2.5

114.0

959

3084

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

3.1

114.0

684

1782

N05AC02

ATC

thioridazine; oral

3.0

113.9

717

1931

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

113.5

2485

11839

E66.8

ICD-10 Finland

Other obesity

1.9

112.8

1772

7557

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

112.5

2104

9535

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

112.3

1531

6182

C10AA05

ATC

atorvastatin; oral

1.4

112.2

7960

49373

C09AA02

ATC

enalapril; systemic

1.6

111.7

3717

19819

P01AB01

ATC

metronidazole; oral, rectal

1.3

111.5

12227

81058

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

111.0

3139

16069

SPAT1234

SPAT

Support of social functional capacity

2.4

110.8

1055

3621

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

110.4

2464

11804

ZY010

NOMESCO Finland

Hospital outpatient

1.9

109.8

1740

7441

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.9

109.7

1724

7351

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

109.0

11344

74579

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

108.2

1659

7010

N05AN01

ATC

lithium; oral

2.5

108.1

906

2908

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.4

107.6

978

3278

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.0

107.4

470

952

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

2.8

106.6

747

2157

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

106.3

2938

14941

C07AB02

ATC

metoprolol; systemic

1.5

106.3

3782

20469

N05AF05

ATC

zuclopenthixol; systemic

4.2

105.8

433

824

A08

ICPC

Swelling

2.4

105.6

954

3188

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

105.3

1724

7458

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.5

105.2

406

729

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

897.4

104.9

112

I50

ICD-10 Finland

Heart failure

4.9

104.4

371

611

N17.8

ICD-10 Finland

Other acute renal failure

6.3

104.3

301

385

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

8.2

104.3

251

245

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

104.1

1278

4937

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.2

104.1

588

1467

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

104.0

1149

4237

4830A

ICD-9 Finland

Pneumonia due to other specified organism, Mycoplasma pneumoniae[PNEUMONIA E MYCOPLASMA PNEUMONIAE]

+∞

104.0

109

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

104.0

1493

6151

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.9

103.9

702

1981

JN4CD

NOMESCO Finland

Very extensive body CT

2.6

103.3

843

2664

E87.5

ICD-10 Finland

Hyperkalaemia

5.7

103.2

323

459

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

102.5

1811

8045

A04AA02

ATC

granisetron; systemic, transdermal

1.9

102.1

1588

6743

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

3.1

101.7

609

1585

J43.9

ICD-10 Finland

Emphysema, unspecified

6.1

101.2

300

398

F10.24

ICD-10 Finland

Alcohol depence active use

3.4

101.0

541

1297

R51.80

ICD-10 Finland

Headache

1.5

100.9

4635

26487

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

4.8

100.7

363

607

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

100.7

2407

11754

UKC02

NOMESCO Finland

Cystoscopy

1.6

100.4

2721

13755

N03AX14

ATC

levetiracetam; systemic

2.7

100.3

767

2336

N06AB06

ATC

sertraline; oral

1.5

100.3

3512

18922

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

100.1

1286

5066

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.1

99.9

1309

5198

RS221

NOMESCO Finland

3.3

99.9

543

1317

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.8

99.6

2011

9333

A02BA02

ATC

ranitidine; systemic

1.5

99.5

4598

26300

L04AA01

ATC

[U] ciclosporin; systemic

3.5

99.5

515

1203

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

7.3

99.0

258

286

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.7

98.9

367

633

N06AX21

ATC

duloxetine; oral

1.6

98.9

3253

17266

B03XA01

ATC

erythropoietin; parenteral

7.2

98.7

258

287

A01AB09

ATC

miconazole; local oral

1.7

98.7

2251

10839

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.9

98.4

643

1775

E0000UV

ATC

1.3

98.0

11981

80209

A10BH01

ATC

sitagliptin; oral

1.8

98.0

1850

8400

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

4.4

97.9

382

694

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

97.4

3139

16577

A10AE05

ATC

insulin detemir; parenteral

2.0

97.4

1444

6022

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

97.1

10234

67119

F05.9

ICD-10 Finland

Delirium, unspecified

4.3

96.7

386

717

N06AX03

ATC

mianserin; oral

2.0

96.7

1287

5142

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.2

96.4

558

1416

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

5.8

96.2

294

406

J01FA10

ATC

azithromycin; systemic

1.3

95.8

20320

145574

SPAT1260

SPAT

Consultation of another employee

1.4

95.8

4686

27088

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

95.4

4575

26343

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.7

95.0

716

2162

S06.0

ICD-10 Finland

Concussion

1.6

94.8

2867

14901

M54.5

ICD-10 Finland

Low back pain

1.3

94.7

9899

64795

WF004

NOMESCO Finland

Palliative radiotherapy

4.0

94.6

414

839

R41.0

ICD-10 Finland

Disorientation, unspecified

3.3

94.5

520

1273

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

94.5

1001

3620

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

94.4

1175

4564

A29

ICPC

General symptom/complaint other

1.6

94.2

2628

13376

R4120

NOMESCO Finland

Occupational therapy

1.8

93.9

1731

7797

RS220

NOMESCO Finland

3.5

93.7

485

1133

A02BC03

ATC

lansoprazole; oral

1.3

93.4

7513

47305

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

93.4

3093

16432

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

6.3

93.4

268

341

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.7

93.2

4588

48589

NHQ40

NOMESCO Finland

Amputation of toe

4.9

92.9

329

540

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

92.8

4297

24557

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.3

92.6

954

3404

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

92.5

1267

5120

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

92.3

1646

7329

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

3.0

92.3

583

1574

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

91.9

5730

34602

S22.3

ICD-10 Finland

Fracture of rib

1.9

91.8

1495

6448

V03AA01

ATC

3.3

91.6

505

1238

SPAT1104

SPAT

Monitoring of emergency patient

1.8

91.5

1591

7025

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

91.4

1856

8622

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.8

91.3

638

1840

R42

ICD-10 Finland

Dizziness and giddiness

1.4

91.3

4939

29073

N05BE01

ATC

buspirone; oral

2.3

91.3

906

3174

A01

ICPC

Pain general/multiple sites

1.7

91.3

1947

9184

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.9

91.3

407

839

G72.8

ICD-10 Finland

Other specified myopathies

4.5

91.3

353

636

A10BB12

ATC

glimepiride; oral

2.2

91.2

976

3546

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

91.2

2280

11262

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.5

91.1

776

2512

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

90.9

3125

16742

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

90.8

2263

11169

JDB10

NOMESCO Finland

Percutaneous gastrostomy

4.7

90.6

332

566

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

90.5

2107

10201

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

90.4

2016

9637

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

265.4

90.3

100

A07AA09

ATC

vancomycin; oral

4.3

89.5

356

660

K78

ICPC

Atrial fibrillation/flutter

2.2

89.2

941

3397

B05DA

ATC

Isotonic solutions

6.0

88.8

265

355

R03BA08

ATC

ciclesonide; inhalant

1.6

88.6

2363

11880

EBA30

NOMESCO Finland

Excision of root of tooth

2.0

88.3

1301

5408

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

88.0

2167

10657

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

88.0

1080

4171

WX704

NOMESCO Finland

Intubation

1.7

87.9

1942

9255

ZZA00

NOMESCO Finland

Split skin graft

2.7

87.8

637

1881

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

87.8

1065

4092

R55

ICD-10 Finland

Syncope and collapse

1.7

87.7

2158

10608

WX402

NOMESCO Finland

General anaesthesia

1.4

87.7

4845

28609

SPAT1325

SPAT

Vaccination

1.3

87.7

8266

53205

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

87.7

2460

12533

V03AE02

ATC

sevelamer; oral

7.6

87.5

221

234

Z49.0

ICD-10 Finland

Preparatory care for dialysis

5.2

87.4

293

453

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.6

87.1

703

2209

Z49.2

ICD-10 Finland

Other dialysis

6.1

87.0

256

337

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.5

86.7

717

2284

C02AC05

ATC

moxonidine; oral

2.3

86.7

875

3091

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

86.7

3027

16269

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

4.4

86.6

340

622

D70.82

ICD-10 Finland

Drug-induced neutropenia

3.2

86.5

493

1239

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.3

86.5

470

1140

TFP20

NOMESCO Finland

Cardiodefibrillation

2.0

86.5

1177

4744

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.7

85.8

402

866

XF404

NOMESCO Finland

Ambulatory ECG

1.7

85.8

2016

9782

TK810

NOMESCO Finland

Hemofiltration

6.7

85.7

235

281

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

12.0

85.6

168

112

49099

ICD-8 Finland

Bronchitis, unspecified

3.8

85.5

394

837

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

6.3

85.2

244

310

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.2

85.1

939

3459

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.7

85.0

1757

8204

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

84.9

4793

28395

A10BH05

ATC

linagliptin; oral

2.5

84.8

732

2387

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

84.7

1585

7167

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.1

84.5

358

705

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.2

84.4

486

1231

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

84.3

2804

14893

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.8

84.2

578

1648

ZX112

NOMESCO Finland

Subcutaneous

2.9

84.1

570

1614

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

84.0

1390

6030

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

9.3

83.9

188

163

K92.1

ICD-10 Finland

Melaena

2.2

83.7

923

3401

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

83.7

755

2521

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.8

83.3

594

1736

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.9

83.2

540

1484

J01DA06

ATC

[U] cefuroxime; systemic

1.4

83.0

4201

24383

46599

ICD-8 Finland

Acute upper respiratory infection of multiple or unspecified sites

1.8

83.0

1683

7811

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.0

82.8

508

1346

SPAT1324

SPAT

Screening procedure

0.7

82.5

3592

38881

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.9

82.4

221

256

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

3.4

82.4

427

999

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

82.2

2315

11795

N05BA12

ATC

alprazolam; oral

1.5

82.1

2847

15264

S29

ICPC

Skin symptom/complaint other

1.4

82.0

4191

24366

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.9

81.9

1322

5684

SPAT1252

SPAT

Overall medication plan or its review

1.9

81.9

1339

5782

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.7

81.5

617

1869

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.9

81.3

361

742

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.2

81.3

881

3219

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

81.2

2476

12871

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

4.4

80.9

315

572

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.7

80.8

594

1769

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

80.2

2221

11267

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.9

80.0

538

1515

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

79.8

1814

8710

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

3.2

79.7

448

1114

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

79.7

2759

14785

N07BA03

ATC

varenicline; oral

1.7

79.5

1644

7676

X58

ICD-10 Finland

Exposure to other specified factors

1.4

79.3

4087

23786

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

79.3

8177

53153

S72.0

ICD-10 Finland

Fracture of neck of femur

3.2

79.2

456

1155

C08CA13

ATC

lercanidipine; oral

1.6

78.8

2484

13013

K92.0

ICD-10 Finland

Haematemesis

2.9

78.7

527

1479

K07

ICPC

Swollen ankles/oedema

2.3

78.6

762

2640

R13

ICD-10 Finland

Dysphagia

1.8

78.4

1398

6220

S01.0

ICD-10 Finland

Open wound of scalp

1.7

78.0

1630

7633

C08CA02

ATC

felodipine; oral

1.8

77.6

1479

6726

K02.1

ICD-10 Finland

Caries of dentine

1.2

77.6

19337

139411

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

4.0

77.5

339

688

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

5.0

77.2

267

428

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

77.2

1549

7161

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.3

77.0

772

2718

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.5

77.0

2601

13854

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

4.9

76.9

274

454

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.4

76.7

301

551

N03AF02

ATC

oxcarbazepine; oral

2.1

76.3

903

3431

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.5

76.2

391

908

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.2

76.2

850

3146

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

76.2

3314

18651

XG460

NOMESCO Finland

Short time oxymetry

3.8

75.9

353

756

196

Kela drug reimbursment

Paricalcitol and cinacalcet

7.7

75.9

189

196

N05AB01

ATC

dixyrazine; systemic

3.6

75.7

368

818

Z72.0

ICD-10 Finland

Tobacco use

2.3

75.6

768

2721

H3603, E103

ICD-10 Finland

3.3

75.5

417

1025

D07AC01

ATC

betamethasone; topical

1.3

75.4

9259

61496

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.5

75.2

616

1954

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

75.2

2190

11250

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

75.1

2597

13903

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

75.1

2275

11801

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

7.2

75.0

196

219

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

75.0

1881

9285

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

74.7

985

3918

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.4

74.6

389

915

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.6

74.6

234

335

SPAT1097

SPAT

Recording of ECG

1.5

74.4

3076

17123

R29

ICPC

Respiratory symptom/complaint other

1.7

74.4

1704

8198

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.9

74.2

260

423

G04CA02

ATC

tamsulosin; oral

1.6

74.0

2217

11465

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.7

74.0

349

757

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.6

73.9

361

806

P01BA02

ATC

hydroxychloroquine; oral

1.6

73.8

2223

11510

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

4.3

73.1

290

537

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.0

72.8

453

1213

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

7.8

72.8

180

185

Z94.2

ICD-10 Finland

Lung transplant status

19.3

72.4

118

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.8

72.3

1304

5822

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

2.5

72.1

600

1919

F61.0

ICD-10 Finland

Mixed personality disorders

2.4

72.1

636

2099

J96.9

ICD-10 Finland

Respiratory failure, unspecified

8.5

71.8

169

160

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

71.8

3313

18850

R07.3

ICD-10 Finland

Other chest pain

1.6

71.8

2206

11478

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.3

71.7

710

2486

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.2

71.4

747

2685

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.4

71.1

367

857

J16.8

ICD-10 Finland

Pneumonia due to other specified infectious organisms

42.3

71.0

B01AB04

ATC

dalteparin; parenteral

1.9

71.0

1055

4398

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

24.0

70.9

108

S76

ICPC

Skin infection other

1.9

70.7

1190

5190

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

70.7

7176

46421

B05DB

ATC

Hypertonic solutions

5.8

70.5

214

294

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

1.9

70.1

1062

4459

120

Kela drug reimbursment

Hypogammaglobulinaemia

11.9

70.1

138

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

70.0

17936

129025

JAH00

NOMESCO Finland

Laparotomy

2.4

69.9

628

2093

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

69.8

1651

8015

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.4

69.8

618

2045

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.6

69.7

568

1796

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.3

69.7

727

2609

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.4

69.7

664

2282

C90.0

ICD-10 Finland

Multiple myeloma

5.2

69.5

233

361

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

13.1

69.5

131

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.6

69.5

553

1725

S10

ICPC

Boil/carbuncle

1.8

69.4

1390

6420

L01CA04

ATC

vinorelbine; systemic

5.3

69.1

228

347

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

3.8

69.1

320

684

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

69.0

2414

12948

U04

ICPC

Incontinence urine

2.1

68.9

847

3274

C09CA01

ATC

losartan; oral

1.3

68.4

5036

31076

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

3.4

68.3

359

851

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.1

68.3

853

3319

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

68.2

2891

16162

ZY000

NOMESCO Finland

Hospital inpatient

2.8

68.2

476

1374

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2.6

68.2

534

1650

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

68.1

1422

6653

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

3.6

68.0

336

758

E66.9

ICD-10 Finland

Obesity, unspecified

2.0

67.9

999

4147

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

4.4

67.7

265

485

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

67.5

23300

172465

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

67.5

1207

5372

P99

ICPC

Psychological disorders other

2.0

67.3

905

3628

J80

ICD-10 Finland

Adult respiratory distress syndrome

15.9

67.1

117

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.6

67.0

520

1599

J01EA01

ATC

trimethoprim; systemic

1.3

66.9

6497

41733

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

66.8

1001

4184

R74

ICPC

Upper respiratory infection acute

1.2

66.6

9675

65358

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

66.6

2647

14597

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

4.3

66.5

268

505

M48.0

ICD-10 Finland

Spinal stenosis

1.6

66.4

2123

11149

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.4

66.2

606

2040

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.6

66.0

515

1589

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.7

66.0

1365

6367

SPAT1167

SPAT

Insertion of urinary catheter

3.0

65.9

404

1069

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

4.0

65.9

282

562

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

65.8

1779

8955

4828X

ICD-9 Finland

Other bacterial pneumonia, Pneumonia due to other specified bacteria

+∞

65.8

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.9

65.8

436

1218

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.7

65.8

495

1495

T89

ICPC

Diabetes insulin dependent

1.8

65.7

1169

5193

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

65.7

1914

9822

UJD02

NOMESCO Finland

Gastroscopy

1.9

65.6

1050

4497

N06AB10

ATC

escitalopram; oral

1.3

65.4

6319

40545

L03AA13

ATC

pegfilgrastim; parenteral

1.9

65.3

981

4106

ZXD35

NOMESCO Finland

Usual procedure

2.0

65.0

842

3324

B03BA03

ATC

hydroxocobalamin; parenteral

2.0

64.8

926

3802

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.5

64.8

561

1834

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.9

64.7

285

583

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.9

64.5

417

1145

R52.9

ICD-10 Finland

Pain, unspecified

1.5

64.1

2126

11256

I25.2

ICD-10 Finland

Old myocardial infarction

2.3

64.1

648

2293

R01AD08

ATC

fluticasone; nasal

1.3

64.0

8691

58199

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.3

63.9

619

2143

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

63.9

2986

17009

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.9

63.9

413

1134

A10AA02

ATC

2.0

63.7

858

3442

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.8

63.5

436

1247

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

63.5

2501

13761

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.4

63.4

574

1922

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

9.8

63.3

137

112

N06AB05

ATC

paroxetine; oral

1.6

63.3

1819

9300

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

4.0

63.3

275

556

G41.9

ICD-10 Finland

Status epilepticus, unspecified

6.1

63.3

186

246

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.7

63.0

470

1412

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

62.7

7917

52529

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.1

62.6

800

3143

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

62.4

1628

8118

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

62.3

11524

79816

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

62.3

1638

8185

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

62.2

959

4051

L04AX04

ATC

lenalidomide; oral

8.6

62.1

145

136

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

5.5

62.0

196

284

B34.9

ICD-10 Finland

Viral infection, unspecified

2.0

62.0

864

3514

OAB43

SPAT

0.8

61.9

3923

40354

C03AA03

ATC

hydrochlorothiazide; oral

1.6

61.9

1669

8393

5CM18

NOMESCO Finland

9.5

61.8

136

115

XA800

NOMESCO Finland

Neuropsychological investigation

1.8

61.6

1159

5246

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

4.3

61.6

245

456

R31

ICD-10 Finland

Unspecified haematuria

1.7

61.5

1445

6998

J01CF05

ATC

flucloxacillin; systemic

1.9

61.4

943

3977

XKD00

NOMESCO Finland

Uroflowmetry

1.6

61.4

1846

9545

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

61.4

3714

22169

A99

ICPC

Disease/condition unspecnature/site

1.6

61.3

1803

9271

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

11.2

61.3

124

X57

ICD-10 Finland

Unspecified privation

2.3

61.2

584

2007

TGA30

NOMESCO Finland

Thoracocentesis

7.6

61.1

153

161

E000001

ATC

1.3

61.1

5796

37050

P29

ICPC

Psychological sympt/compl other

1.6

61.0

1823

9412

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

60.6

1654

8343

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

60.6

5773

36917

188

Kela drug reimbursment

Psychosis requiring demanding treatment

2.9

60.5

391

1075

3AC01

NOMESCO Finland

3.5

60.5

307

709

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

519.5

60.3

153

Kela drug reimbursment

Lenalidomid

7.7

60.1

150

157

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.7

60.0

220

377

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.2

60.0

674

2504

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

1.9

59.9

958

4103

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

4.3

59.8

241

455

A09AA02

ATC

multienzymes (lipase, protease etc.)

2.7

59.7

443

1328

K65.0

ICD-10 Finland

Acute peritonitis

3.8

59.6

271

571

RS222

NOMESCO Finland

3.2

59.5

343

870

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.6

59.3

291

654

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

3.1

59.3

350

905

N05AD03

ATC

melperone; systemic

3.6

59.3

287

638

C01BD01

ATC

amiodarone; systemic

2.6

59.2

456

1398

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

2.5

59.2

485

1540

J15.0

ICD-10 Finland

Pneumonia due to Klebsiella pneumoniae

+∞

59.2

4808X

ICD-9 Finland

Viral pneumonia, Pneumonia due to other virus not elsewhere classified

+∞

59.2

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

58.8

1079

4845

RD210

NOMESCO Finland

2.3

58.7

570

1978

J02AC03

ATC

voriconazole; systemic

14.8

58.6

105

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.8

58.6

4065

41345

P16

ICPC

Acute alcohol abuse

2.5

58.2

498

1618

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.4

58.1

528

1772

XF402

NOMESCO Finland

ECG with work load test

1.5

58.0

2188

11918

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

5.7

58.0

178

249

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

58.0

15605

111921

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.3

58.0

571

1996

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

3.1

57.9

350

921

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.9

57.8

971

4230

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.4

57.7

307

736

XQ800

NOMESCO Finland

Prick test

1.5

57.7

2332

12894

WX726

NOMESCO Finland

High-flow oxygen therapy

173.5

57.5

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.5

57.4

473

1505

J01DC02

ATC

cefuroxime; systemic

1.6

57.3

1634

8334

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.9

57.3

254

524

GDG10

NOMESCO Finland

Bilateral transplantation of lung

22.7

57.0

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.8

57.0

1039

4654

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

57.0

1717

8879

R04.0

ICD-10 Finland

Epistaxis

1.7

56.9

1223

5771

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.3

56.9

580

2062

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.6

56.8

1511

7570

WVA20

NOMESCO Finland

Medicine administration

2.4

56.7

535

1830

TJD20

NOMESCO Finland

Change of gastrostomy tube

7.7

56.5

140

145

N05CD02

ATC

nitrazepam; oral

3.1

56.5

333

859

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

56.5

1248

5937

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

56.5

2794

16074

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

5.0

56.3

193

308

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

1.8

56.3

1011

4508

I20.09

ICD-10 Finland

Unstable angina

2.0

56.2

731

2891

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

56.2

6256

40782

SPAT1211

SPAT

Application of soft bandage

1.5

56.1

2144

11710

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

56.1

4120

25346

SPAT1251

SPAT

Organisation of medication

2.1

56.0

708

2769

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4.2

56.0

227

431

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.2

55.8

317

798

Z00.0

ICD-10 Finland

General medical examination

1.3

55.8

4725

29689

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

55.6

1750

9144

Z2445

NOMESCO Finland

Psychologist

1.7

55.6

1271

6105

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

2.7

55.5

399

1175

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

55.5

12097

84910

-50

ICPC

Medication/prescr/renewal

1.9

55.4

924

4015

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.1

55.3

324

834

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

4.5

55.2

211

378

WX212

NOMESCO Finland

Femoral plexus blockade

2.8

55.1

377

1076

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.0

55.1

776

3168

A10AA01

ATC

2.0

55.1

801

3311

R03DC01

ATC

zafirlukast; oral

2.7

55.1

409

1228

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

3.4

55.0

282

657

NF3AA

NOMESCO Finland

Femur X-ray examination

2.8

54.9

388

1130

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

54.9

1457

7294

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

54.8

2252

12488

A01AB04

ATC

amphotericin B; local oral

1.8

54.8

985

4391

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.1

54.8

332

875

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.2

54.8

598

2194

H05BX01

ATC

cinacalcet; oral

5.8

54.8

167

232

WZA90

NOMESCO Finland

Other doctors statement

1.3

54.8

6787

44809

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.1

54.8

629

2361

J98.1

ICD-10 Finland

Pulmonary collapse

6.7

54.7

149

178

N02AA01

ATC

morphine; systemic, rectal

5.3

54.7

179

271

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

6.1

54.7

160

211

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

3.0

54.6

341

917

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

4.9

54.5

192

316

K59.0

ICD-10 Finland

Constipation

1.8

54.4

1095

5061

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

54.4

1221

5832

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.3

54.4

5424

34840

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

5.6

54.3

169

241

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.4

54.1

174

258

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.1

54.1

686

2687

C08DB01

ATC

diltiazem; oral

2.1

54.0

621

2331

XG405

NOMESCO Finland

Education on PEF monitoring

2.7

54.0

406

1229

WYA20

NOMESCO Finland

Home visit

3.8

53.9

249

533

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

2.3

53.8

518

1789

H26.3

ICD-10 Finland

Drug-induced cataract

4.4

53.7

208

378

Z72.2

ICD-10 Finland

Drug use

3.8

53.7

243

511

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

5.7

53.6

164

229

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.1

53.6

676

2643

C07AG02

ATC

carvedilol; oral

1.8

53.6

926

4076

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.7

53.5

398

1196

N05CF02

ATC

zolpidem; oral

1.3

53.5

4928

31311

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

53.4

3268

19518

348

Kela drug reimbursment

Roflumilast

19.7

53.3

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

53.1

1410

7058

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.3

53.1

513

1775

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.0

53.1

741

3016

29599

ICD-8 Finland

Schizophrenia, Unspecified type

5.2

53.0

176

271

Z29.0

ICD-10 Finland

Isolation

7.3

53.0

136

149

V03AE03

ATC

lanthanum carbonate; oral

6.7

52.7

143

170

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.0

52.7

755

3103

SPAT1059

SPAT

Spirometry at the office

1.7

52.6

1149

5446

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.3

52.5

539

1922

R01AD09

ATC

mometasone; nasal

1.2

52.5

14302

102342

H25.8

ICD-10 Finland

Other senile cataract

1.7

52.5

1227

5930

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.0

52.5

674

2654

I95.1

ICD-10 Finland

Orthostatic hypotension

2.7

52.5

388

1162

R28

ICPC

Limited function/disability (R)

3.3

52.4

281

679

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.4

52.3

273

646

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.1

52.3

304

779

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

6.2

52.3

151

196

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.9

52.2

341

945

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

4.9

52.2

183

300

F20.10

ICD-10 Finland

Raise schizophrenia continuously

4.8

52.2

187

314

SPAT1310

SPAT

Counselling related to known health issue

1.2

52.1

8714

59451

K77

ICPC

Heart failure

4.1

52.1

215

416

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.2

51.9

542

1947

GDC00

NOMESCO Finland

Lobectomy of lung

7.1

51.9

136

154

D07AB08

ATC

desonide; topical

1.4

51.9

2693

15621

L03

ICPC

Low back symptom/complaint

1.3

51.9

6573

43473

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.1

51.8

307

797

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

3.2

51.6

286

708

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

3.7

51.6

244

533

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.1

51.6

594

2232

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.3

51.5

500

1736

F20.5

ICD-10 Finland

Residual schizophrenia

4.6

51.4

193

340

WX320

NOMESCO Finland

Spinalanesthesy

1.3

51.3

5252

33824

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.8

51.1

345

978

R78

ICPC

Acute bronchitis/bronchiolitis

2.2

51.1

549

2001

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.4

51.0

483

1655

I95.9

ICD-10 Finland

Hypotension, unspecified

3.5

50.9

255

584

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.8

50.9

863

3775

K85

ICD-10 Finland

Acute pancreatitis

2.7

50.8

374

1116

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.6

50.8

395

1217

P18

ICPC

Medication abuse

3.8

50.7

229

481

S20.2

ICD-10 Finland

Contusion of thorax

1.7

50.6

1120

5327

E000003

ATC

1.7

50.6

1194

5785

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

50.6

12420

87930

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.7

50.6

1102

5219

TK820

NOMESCO Finland

Peritoneal dialysis

5.6

50.5

158

227

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

50.4

1446

7384

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.0

50.4

720

2958

F20

ICD-10 Finland

Schizophrenia

3.5

50.4

254

585

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.3

50.3

489

1698

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.3

50.3

498

1747

B02.9

ICD-10 Finland

Zoster without complication

1.7

50.3

1110

5278

L84

ICD-10 Finland

Corns and callosities

2.0

50.2

731

3024

M05BA07

ATC

risedronic acid; oral

2.2

50.2

560

2075

S72.1

ICD-10 Finland

Pertrochanteric fracture

3.8

49.9

224

468

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.8

49.9

229

488

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

49.9

1617

8506

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

49.9

1751

9384

R52.2

ICD-10 Finland

Other chronic pain

1.9

49.8

829

3600

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

3.3

49.8

270

658

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

4.9

49.8

175

288

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

4.3

49.6

195

360

R52.0

ICD-10 Finland

Acute pain

1.9

49.6

820

3554

WW300

NOMESCO Finland

Transfer of autologic stem cells

5.7

49.6

152

213

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

49.6

1396

7096

A10BB01

ATC

glibenclamide; oral

3.0

49.4

304

809

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.9

49.4

330

929

J01FA01

ATC

erythromycin; systemic

1.3

49.2

4333

27332

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.7

48.9

357

1062

1240

FHL

Bronchoscopy

4.4

48.8

190

348

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

5.4

48.6

157

235

C07AA05

ATC

propranolol; systemic

1.3

48.5

5629

36795

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

12.1

48.5

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

5.2

48.4

161

249

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

48.4

569

2159

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

4.8

48.4

171

283

ZX100

NOMESCO Finland

Oral

2.9

48.4

320

896

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.8

48.3

329

938

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.9

48.2

703

2912

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.4

48.2

253

602

P20

ICPC

Memory disturbance

1.6

48.1

1287

6452

K56.7

ICD-10 Finland

Ileus, unspecified

3.0

48.1

302

815

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

5.6

48.1

150

215

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.1

48.1

587

2264

N06AA06

ATC

trimipramine; systemic

2.0

48.1

640

2557

R40.2

ICD-10 Finland

Coma, unspecified

4.0

48.0

205

410

R03DX07

ATC

roflumilast; oral

19.9

48.0

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

5.2

48.0

159

245

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.6

48.0

381

1189

N05AL01

ATC

sulpiride; systemic

2.5

48.0

399

1280

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.7

48.0

965

4463

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

6.0

47.9

142

191

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.2

47.9

524

1926

L05

ICPC

Flank/axilla symptom/complaint

1.6

47.8

1224

6067

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

2.1

47.7

591

2292

S21

ICPC

Skin texture symptom/complaint

1.4

47.7

2805

16623

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

47.6

941

4327

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

47.6

11239

79162

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.7

47.5

996

4664

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.7

47.5

354

1066

SPAT1053

SPAT

Memory test

1.5

47.5

1574

8322

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

8.6

47.4

110

103

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.1

47.3

547

2061

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.9

47.3

304

835

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

6.3

47.3

134

170

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.1

47.3

561

2139

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

3.0

47.2

293

786

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.7

47.2

1022

4830

G04BD04

ATC

oxybutynin; oral, transdermal

1.7

47.1

1008

4749

J11.0

ICD-10 Finland

Influenza with pneumonia, virus not identified

4.9

47.1

165

271

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.3

47.1

476

1688

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

3.9

47.0

205

418

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

46.9

1705

9203

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

46.9

911

4167

SPAT1265

SPAT

Breathalyser

2.8

46.8

330

960

SPAT1197

SPAT

Extensive health check-up of expecting family

0.7

46.7

2079

22585

Z72.1

ICD-10 Finland

Alcohol use

2.6

46.6

355

1082

TAB00

NOMESCO Finland

Lumbar puncture

1.6

46.5

1178

5822

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.2

46.5

7579

51455

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

8.0

46.4

112

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.7

46.4

329

963

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.8

46.3

836

3732

F20.0

ICD-10 Finland

Paranoid schizophrenia

3.2

46.3

256

634

L14

ICPC

Leg/thigh symptom/complaint

1.5

46.2

1590

8478

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.0

45.9

628

2536

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

3.7

45.9

218

479

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.4

45.8

427

1455

N05CD08

ATC

midazolam; nasal, systemic

2.3

45.8

459

1620

R01

ICPC

Pain respiratory system

2.3

45.8

435

1497

N02AC04

ATC

dextropropoxyphene; oral

2.1

45.6

578

2264

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.7

45.6

164

277

Z50.1

ICD-10 Finland

Other physical therapy

1.6

45.6

1200

5993

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.7

45.6

1003

4765

H26.4

ICD-10 Finland

After-cataract

1.6

45.4

1128

5548

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.4

45.3

240

575

J86.00

ICD-10 Finland

Empyema with broncho-pleural fistula

24.7

45.3

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.5

45.2

372

1187

D11

ICPC

Diarrhoea

1.3

45.2

3186

19437

WX290

NOMESCO Finland

Other blockade of nerve

1.2

45.2

14997

108660

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.4

45.2

407

1361

SPAT1058

SPAT

PEF monitoring instruction

1.5

45.2

1905

10609

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.2

45.2

490

1795

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.4

45.1

238

569

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

5.0

45.0

155

250

Angiography of the heart and coronary arteries

2.1

45.0

546

2102

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

44.9

1000

4765

W78

ICPC

Pregnancy

0.7

44.9

2363

25043

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

44.7

3160

19282

H03AA01

ATC

levothyroxine sodium; systemic

1.2

44.7

6125

40782

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

3.8

44.6

201

422

N06AX12

ATC

bupropion; oral

1.5

44.6

1904

10628

WF002

NOMESCO Finland

Radical radiotherapy

1.9

44.6

707

3018

A07EC01

ATC

sulfasalazine; oral, rectal

1.4

44.5

2033

11505

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

3.6

44.5

218

492

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

9.0

44.4

100

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

3.2

44.4

252

636

K90

ICPC

Stroke/cerebrovascular accident

2.5

44.4

362

1148

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.4

44.3

408

1382

R03AC18

ATC

indacaterol; inhalant

5.0

44.3

151

241

R03BB07

ATC

umeclidinium bromide; inhalant

4.0

44.2

188

375

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

2.8

44.2

311

905

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

7.2

44.1

114

127

A06AH03

ATC

naloxegol; oral

3.3

44.1

234

562

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

44.0

1707

9343

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

3.2

44.0

249

627

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

8.0

44.0

106

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.6

43.9

1298

6678

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

43.9

816

3679

SPAT1240

SPAT

Therapeutic discussion

1.3

43.8

3340

20609

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

4.9

43.8

154

254

N06AG02

ATC

moclobemide; oral

1.7

43.8

1056

5147

J05AB11

ATC

valaciclovir; oral

1.3

43.8

3291

20267

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

4.1

43.7

183

360

D07AA02

ATC

hydrocortisone; topical

1.3

43.7

3787

23807

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

43.6

2850

17178

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

43.6

1700

9318

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

43.5

2654

15816

M25.5

ICD-10 Finland

Pain in joint

1.2

43.5

8132

55915

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

43.4

4355

27916

6BA02

NOMESCO Finland

5.6

43.3

135

194

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.2

43.3

247

626

Z08

ICPC

Social welfare problem

2.5

43.3

355

1130

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.0

43.3

274

745

D12

ICPC

Constipation

2.0

43.3

595

2411

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.3

43.3

415

1435

R10.0

ICD-10 Finland

Acute abdomen

1.8

43.2

768

3414

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.2

43.2

461

1676

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.0

43.2

555

2188

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.7

43.2

317

948

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

6.2

43.1

124

161

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.1

43.1

250

640

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

42.9

660

2789

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.9

42.9

685

2934

NGQ20

NOMESCO Finland

Amputation of lower leg

7.0

42.8

113

130

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

42.8

1663

9103

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

2.7

42.8

310

919

J42

ICD-10 Finland

Unspecified chronic bronchitis

3.0

42.7

258

681

Z94.1

ICD-10 Finland

Heart transplant status

7.1

42.7

111

125

C08CA05

ATC

nifedipine; systemic

1.6

42.7

1056

5185

A02BA04

ATC

nizatidine; systemic

1.5

42.6

1477

7885

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.7

42.5

302

885

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

4.1

42.5

175

339

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.8

42.5

726

3184

CKC15

NOMESCO Finland

Panretinal photocoagulation

3.7

42.5

201

441

PE1AT

NOMESCO Finland

Femoral artery PTA

4.4

42.4

164

299

SPD00

NOMESCO Finland

Fitting and preparation of total teeth prosthesis

3.3

42.4

230

562

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

4.7

42.4

155

267

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

42.3

17141

125943

P19

ICPC

Drug abuse

2.6

42.3

327

1008

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.8

42.3

3241

32684

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

42.3

1134

5689

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

8.1

42.2

101

100

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.4

42.1

395

1349

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

4.1

42.0

175

343

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

3.6

42.0

200

441

U05

ICPC

Urination problems other

1.8

42.0

740

3279

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.1

41.9

516

1997

RS230

NOMESCO Finland

4.0

41.9

181

367

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.9

41.8

185

383

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

1.9

41.8

622

2595

00920

ICD-8 Finland

Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)

1.7

41.8

908

4299

2951C

ICD-9 Finland

Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]

9.3

41.7

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.6

41.7

1225

6292

K99

ICPC

Cardiovascular disease other

2.4

41.6

389

1326

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.6

41.6

1257

6501

SPF30

NOMESCO Finland

Soling for prothesis

2.7

41.5

300

889

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

6.0

41.5

122

163

R5110

SPAT

2.1

41.5

486

1844

R04

ICPC

Breathing problem other

1.8

41.5

784

3555

E000006

ATC

1.5

41.5

1736

9651

UGC02

NOMESCO Finland

Rigid bronchoscopy

6.4

41.5

116

145

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

4.7

41.5

149

252

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

3.0

41.4

254

678

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

7.3

41.3

106

117

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.4

41.3

161

296

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

6.6

41.3

113

137

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.9

41.3

273

765

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.5

41.3

1511

8167

R07.1

ICD-10 Finland

Chest pain on breathing

2.4

41.3

379

1282

F34.1

ICD-10 Finland

Dysthymia

1.7

41.2

992

4836

Z03

ICPC

Housing/neighbourhood problem

3.7

41.2

190

408

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

5.0

41.2

140

223

L04AA13

ATC

leflunomide; oral

1.9

41.2

643

2732

M02AA07

ATC

piroxicam; topical

1.2

41.1

8947

62346

J16.0

ICD-10 Finland

Chlamydial pneumonia

40.0

41.0

J01CE08

ATC

benzathine benzylpenicillin; parenteral

3.3

41.0

224

551

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.0

41.0

545

2181

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

2.7

40.9

306

923

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.8

40.9

742

3322

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

1.7

40.8

882

4167

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.5

40.7

333

1059

J85.2

ICD-10 Finland

Abscess of lung without pneumonia

16.7

40.7

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

4.2

40.7

164

312

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.4

40.6

367

1232

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.7

40.6

971

4723

J01GB01

ATC

tobramycin; inhalant, parenteral

52.0

40.6

M03BX01

ATC

baclofen; systemic

2.2

40.6

426

1539

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

40.6

1103

5553

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

2.6

40.5

308

940

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

3.8

40.5

183

386

SPAT1281

SPAT

Other administrative function

1.4

40.5

1896

10774

S01

ICPC

Pain/tenderness of skin

1.7

40.4

942

4553

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.5

40.3

1339

7081

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

3.2

40.2

224

559

H36.01

ICD-10 Finland

Diabetic maculopathy

2.8

40.2

280

812

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

3.0

40.1

246

656

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.6

40.1

305

931

U07

ICPC

Urine symptom/complaint other

1.6

40.1

1125

5713

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.8

40.1

733

3290

N03AB02

ATC

phenytoin; systemic

3.1

40.1

231

591

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

3.9

40.0

175

359

321

Kela drug reimbursment

Paricalcitol and cinacalcet

5.0

39.9

137

221

N05AF01

ATC

flupentixol; systemic

2.3

39.9

402

1424

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.8

39.8

699

3094

M01AX17

ATC

nimesulide; oral

1.2

39.8

5598

37319

SPAT1125

SPAT

Stoma care and guidance

3.4

39.8

202

470

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.5

39.7

151

271

M10.0

ICD-10 Finland

Idiopathic gout

2.2

39.7

412

1480

GAB10

NOMESCO Finland

Antero- or postero-lateral thoracotomy

6.1

39.7

115

151

TQW80

NOMESCO Finland

Local dermatologic skincare

2.0

39.7

574

2371

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

3.6

39.6

194

438

SPAT1153

SPAT

Removal of sutures

1.2

39.6

7476

51367

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.1

39.6

458

1728

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

3.6

39.6

191

426

G04BE03

ATC

sildenafil; oral

3.4

39.5

205

485

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

4.4

39.5

153

280

T82

ICPC

Obesity

1.6

39.5

1025

5100

EBA10

NOMESCO Finland

Surgical removal of tooth

1.3

39.5

3694

23443

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

4.6

39.5

146

255

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.5

39.4

335

1090

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.2

39.4

446

1666

GD1LA

NOMESCO Finland

3.0

39.4

241

641

B82

ICPC

Anaemia other/unspecified

2.2

39.3

404

1445

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.7

39.3

843

3975

F60.2

ICD-10 Finland

Dissocial personality disorder

4.6

39.2

145

253

N18

ICPC

Paralysis/weakness

2.6

39.2

313

981

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

5.5

39.2

124

182

5AB14

NOMESCO Finland

7.8

39.2

4801A

ICD-9 Finland

Viral pneumonia, Pneumonia due to respiratory syncytial virus

+∞

39.1

WNF00

NOMESCO Finland

Infection source and contact determination

5.3

39.1

126

189

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.2

39.0

402

1440

J81

ICD-10 Finland

Pulmonary oedema

9.9

39.0

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

39.0

1099

5588

S22.4

ICD-10 Finland

Multiple fractures of ribs

2.4

38.9

361

1229

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.9

38.8

574

2391

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

2.9

38.8

246

672

T74.1

ICD-10 Finland

Physical abuse

1.9

38.8

586

2462

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.8

38.7

2355

24487

5BA08

NOMESCO Finland

4.5

38.7

147

264

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.1

38.6

228

593

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

3.2

38.6

220

558

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.6

38.6

189

427

I26

ICD-10 Finland

Pulmonary embolism

3.1

38.6

222

567

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.2

38.4

218

551

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

2.7

38.4

287

868

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.1

38.3

436

1632

R4130

NOMESCO Finland

Speech therapy

2.1

38.3

448

1699

WX721

NOMESCO Finland

Oxygen concentrator therapy

15.3

38.3

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

3.0

38.3

238

642

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

1.9

38.1

620

2674

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.4

38.1

1651

9240

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.1

38.1

444

1681

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

23.2

38.1

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.1

38.0

451

1722

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.7

38.0

780

3629

L76

ICPC

Fracture: other

2.0

37.9

517

2089

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.0

37.9

162

326

K93

ICPC

Pulmonary embolism

3.2

37.9

208

514

N06AX05

ATC

trazodone; oral

1.8

37.8

667

2958

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.1

37.8

463

1790

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

5.1

37.8

127

200

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

4.8

37.8

134

224

R03BC01

ATC

cromoglicic acid; inhalant

2.1

37.8

467

1813

K03.66

ICD-10 Finland

Tooth plaque

1.5

37.7

1586

8825

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

10.2

37.7

K86.1

ICD-10 Finland

Other chronic pancreatitis

3.3

37.6

206

508

SPAT1172

SPAT

Guidance concerning hydration

2.7

37.6

279

840

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.0

37.6

497

1983

K02.2

ICD-10 Finland

Caries of cementum

1.7

37.6

852

4083

M81.4

ICD-10 Finland

Drug-induced osteoporosis

5.3

37.6

122

185

J15.2

ICD-10 Finland

Pneumonia due to staphylococcus

326.6

37.5

A03FA02

ATC

cisapride; oral, rectal

1.5

37.5

1514

8352

Z01.7

ICD-10 Finland

Laboratory examination

1.3

37.5

2644

16110

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

2.8

37.5

258

741

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

37.5

7481

51637

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.6

37.5

997

4994

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.4

37.4

345

1171

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

3.4

37.4

195

464

L29

ICPC

Musculoskeletal sympt/complt other

1.4

37.4

1674

9431

B01AF01

ATC

rivaroxaban; oral

1.4

37.4

1959

11364

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.5

37.3

306

977

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

5.6

37.3

115

164

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.1

37.2

454

1753

TPX15

NOMESCO Finland

Removal of vascular injection port

4.1

37.2

153

297

R09.1

ICD-10 Finland

Pleurisy

2.2

37.2

409

1509

ZX121

NOMESCO Finland

Central venous catheter

4.3

37.2

146

271

4830X

ICD-9 Finland

Pneumonia due to other specified organism, Mycoplasma pneumoniae[PNEUMONIA ALIA DEFINITA]

+∞

37.2

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

3.2

37.2

210

529

A10BJ02

ATC

liraglutide; parenteral

2.0

37.2

521

2126

U02

ICPC

Urinary frequency/urgency

1.3

37.1

3073

19165

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

3.4

37.1

189

441

L95

ICPC

Osteoporosis

1.9

37.1

542

2250

C08DA01

ATC

verapamil; systemic

1.7

37.1

738

3401

UDC00

NOMESCO Finland

Ear microscopy

1.4

37.1

1627

9130

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

37.1

1305

6993

A10BJ06

ATC

semaglutide; parenteral

1.7

37.1

747

3459

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.1

37.0

466

1823

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.7

37.0

781

3666

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.2

37.0

403

1483

C02EA02

ATC

2.1

36.9

420

1575

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.5

36.9

1296

6937

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.8

36.9

246

693

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

36.9

8836

61988

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.2

36.8

5530

37099

QDA10

NOMESCO Finland

Incision of skin of lower limb

3.4

36.7

188

441

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

36.7

1213

6408

E87.2

ICD-10 Finland

Acidosis

5.0

36.7

124

197

WX213

NOMESCO Finland

Lower leg blockade

3.4

36.6

191

455

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.4

36.5

319

1053

SPAT1379

SPAT

Health check-up of pregnant person

0.7

36.5

1723

18580

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.8

36.5

677

3054

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.8

36.4

664

2978

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

36.4

1251

6669

B81

ICPC

Anaemia vit B12/folate deficiency

1.9

36.4

564

2393

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

2.6

36.3

276

844

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.3

36.3

370

1319

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.7

36.3

267

800

L88

ICPC

Rheumatoid/seropositive arthritis

1.7

36.3

884

4323

G02BA03

ATC

plastic IUD with progestogen

0.8

36.3

2166

22587

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

1.7

36.2

822

3941

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.5

36.2

1447

7965

C02CA01

ATC

prazosin; oral

3.7

36.2

169

368

N05BB01

ATC

hydroxyzine; systemic

1.5

36.2

1553

8675

1XC02

NOMESCO Finland

3.4

36.1

186

438

N03AX18

ATC

lacosamide; systemic

3.1

35.9

214

561

2959C

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]

4.8

35.9

127

212

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

1046

1839

3.99

320.65

2.5

2.6

e6/l

588.1

494.7

1.72

885

1510

(21494815) CD4 cells/100 lymphocytes in Specimen

1202

2345

3.60

319.67

2.2

36.7

42.7

3.27

121

318

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

625

697

6.26

314.63

1.9

1.5

u/ml

26339.7

5355.3

0.61

(3024928) Oxygen saturation in Venous blood

2066

5631

2.60

313.10

4.4

3.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

1014

1786

3.98

310.07

2.6

e9/l

0.2

0.39

885

1507

(3001122) Ferritin [Mass/volume] in Serum or Plasma

25999

147175

1.39

307.77

3.6

2.7

ug/l

176.3

109.0

74.33

24257

137123

(3024980) IgG subclass 4 [Mass/volume] in Serum

1826

4710

2.74

307.67

1.5

1.6

g/l

0.7

0.8

0.74

1369

3554

(3009466) Valproate [Moles/volume] in Serum or Plasma

1730

4175

2.92

307.65

5.9

4.9

umol/l

373.6

370.0

0.41

1520

3638

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

6065

17437

2.57

307.65

9.6

7.1

mmol/l

25.1

24.6

17.19

6004

17302

(3022806) Fractional oxyhemoglobin in Capillary blood

1556

3257

3.37

307.65

2.2

1.6

89.3

90.5

9.96

1536

3200

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1087

1853

4.12

307.65

2.1

2.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

6127

14625

3.12

307.65

2.0

1.5

—

(3026782) Osmolality of Urine

14945

58396

2.03

307.65

3.5

2.5

mosm/kgh2o

528.2

553.4

29.44

13201

49254

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

879

970

6.35

307.65

2.2

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

11427

54176

1.57

307.65

3.6

2.8

mmol/l

2.5

2.4

83.25

9948

47300

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7407

28389

1.92

307.65

2.5

2.2

nmol/l

361.1

376.7

7.33

6839

26213

(3002179) Metamyelocytes/100 leukocytes in Blood

6430

22925

2.05

307.65

5.0

3.7

0.7

0.6

0.52

2046

4284

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1227

857

10.10

307.65

1.7

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

5529

13199

3.09

307.65

11.7

9.1

mmol/l

24.7

24.1

30.61

5108

12431

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5740

21318

1.96

307.65

5.4

3.6

ng/l

110.2

82.9

46.49

5048

18471

(3010421) pH of Blood

2922

6850

3.05

307.65

5.8

2.9

7.4

1.86

2580

5719

(3013826) Glucose [Moles/volume] in Serum or Plasma

36937

185717

1.97

307.65

7.8

4.0

mmol/l

6.9

6.6

105.44

35257

171797

(3027273) Bicarbonate [Moles/volume] in Venous blood

4202

12801

2.37

307.65

4.9

3.0

mmol/l

25.4

25.1

5.69

4061

12425

(3013707) Erythrocyte sedimentation rate by Westergren method

40576

246243

1.43

307.65

5.5

3.7

mm/h

16.2

10.5

307.65

38124

228365

(3015235) Bicarbonate [Moles/volume] in Capillary blood

3016

6175

3.51

307.65

4.4

2.5

mmol/l

25.1

24.3

15.64

2666

5438

(3019060) Gas panel - Arterial blood

6908

15886

3.27

307.65

6.3

4.2

—

(3022096) Basophils/100 leukocytes in Blood

32164

145316

2.14

307.65

8.9

5.6

0.6

0.7

160.56

30673

135247

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1480

1575

6.65

307.65

1.9

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

15561

63406

1.94

307.65

3.3

2.4

e6/l

6.1

5.6

3.17

14001

54868

(40768806) Pleura Pathology biopsy report

1297

1918

4.76

307.65

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

4060

4215

7.08

307.65

1.9

1.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

980

1252

5.49

307.65

1.3

u/l

15.2

13.1

1.16

882

1177

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

2158

5836

2.62

307.65

1.7

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2987

9351

2.28

307.65

3.1

2.0

g/l

3.3

3.0

31.31

2345

7245

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

13635

25602

4.47

307.65

2.1

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

879

970

6.35

307.65

2.2

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

6255

15039

3.10

307.65

1.7

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

3254

6773

3.46

307.65

1.4

1.2

—

(3039000) Anion gap in Blood

2195

5742

2.71

307.65

9.9

5.5

mmol/l

11.3

11.2

0.37

1981

5169

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1105

758

10.26

307.65

1.7

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

11769

45038

2.00

307.65

2.8

2.0

30.3

29.6

18.10

11428

43737

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

23493

126630

1.47

307.65

2.2

1.9

pmol/l

92.8

97.1

37.08

13138

65925

(3033658) Prothrombin time (PT) actual/Normal

17655

79758

1.75

307.65

5.8

3.6

87.7

91.9

80.99

17209

77719

(3037756) Immunofixation for Serum or Plasma

2052

4867

2.99

307.65

1.9

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3290

2915

8.21

307.65

1.6

1.3

—

(3045788) Cell count panel - Pleural fluid

1232

1670

5.19

307.65

1.5

1.4

—

(1616796) Gas panel - Central venous blood

2798

5533

3.62

307.65

4.9

2.8

—

(42870588) Differential panel, method unspecified - Blood

26158

106421

2.24

307.65

8.3

5.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1653

1921

6.10

307.65

2.0

1.5

—

(3030467) Casts [#/volume] in Urine by Automated count

19542

85040

1.87

307.65

4.1

2.9

e6/l

0.5

0.4

13.18

15393

62658

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

3914

11211

2.52

307.65

6.6

3.5

mmol/l

25.1

24.6

17.74

3705

10405

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2833

7698

2.62

307.65

4.4

2.9

mg/l

50.2

40.6

1.62

2272

6256

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

4212

4327

7.17

307.65

1.9

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

7539

27478

2.03

307.65

2.5

2.3

g/l

0.2

39.22

6954

25665

(3036782) Glucose [Moles/volume] in Pleural fluid

1245

1739

5.04

307.65

1.4

1.3

mmol/l

6.4

6.2

1.21

1140

1620

(3019309) Folate [Moles/volume] in Red Blood Cells

12665

52745

1.84

307.65

1.9

1.7

nmol/l

1166.9

0.00

9873

39857

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1104

742

10.48

307.65

1.7

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

2452

6077

2.87

307.65

2.6

2.0

g/l

127.5

132.9

16.58

1779

4490

(3014111) Lactate [Moles/volume] in Serum or Plasma

8450

23691

2.71

307.65

9.6

6.6

mmol/l

1.4

1.3

4.34

8067

22925

(3020891) Body temperature

3366

10792

2.23

307.65

7.1

4.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

10287

30945

2.57

307.65

5.1

3.9

u/l

250.0

239.8

7.15

9824

29204

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

17629

75978

1.86

307.65

2.6

2.2

mg/l

3.1

2.8

37.96

15378

64838

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

32516

151955

2.04

307.65

11.2

5.7

mmol/l

1.2

113.35

27937

127893

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

3144

8959

2.51

307.65

3.3

2.7

g/l

3.9

3.5

37.94

3019

8531

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1658

856

13.76

307.65

1.9

1.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

11649

42606

2.11

307.65

3.3

2.2

g/l

2.3

2.4

101.99

10882

39293

(3024561) Albumin [Mass/volume] in Serum or Plasma

28786

132314

1.97

307.65

6.9

4.4

g/l

33.9

36.3

307.65

27005

122610

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2666

2180

8.81

307.65

1.6

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

7185

28533

1.84

307.65

3.0

2.4

u/l

52.5

43.1

0.39

6149

24449

(3018010) Neutrophils/100 leukocytes in Blood

32988

154138

2.06

307.65

8.7

5.4

59.7

56.2

307.65

31459

144178

(3021960) Folate [Moles/volume] in Serum or Plasma

14381

69043

1.58

307.65

1.7

1.5

nmol/l

19.3

20.5

19.49

12766

59195

(3002582) Erythrocytes [#/volume] in Urine

21317

92802

1.91

307.65

4.2

2.9

e6/l

71.3

84.5

0.65

17132

69802

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

7153

21521

2.48

307.65

3.8

2.5

ng/l

248.9

168.5

30.37

6592

19389

(3022217) INR in Platelet poor plasma by Coagulation assay

9335

36381

1.92

307.65

26.4

21.6

inr

1.4

1.3

8.33

1290

5373

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

5556

16934

2.40

307.65

13.2

8.4

0.7

2.51

5516

16848

(36304419) Bacteria [Presence] in Urine

19004

83303

1.84

307.65

4.0

2.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2766

7458

2.64

307.65

4.3

2.9

ratio

6.7

2.7

0.88

211

601

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

4027

12726

2.28

307.65

4.2

2.8

1.4

1.3

6.57

4007

12663

(3000494) Fungus identified in Specimen by Culture

8830

35741

1.83

307.65

1.8

1.3

—

(3018418) pH of Serum or Plasma

20400

88629

1.90

307.65

6.1

3.6

7.4

4.04

4209

16556

(3028192) IgG subclass 2 [Mass/volume] in Serum

1357

2826

3.38

307.65

1.4

g/l

2.7

3.1

9.23

984

1919

(3018095) Leukocytes [#/volume] in Urine

23545

110990

1.77

307.65

4.9

3.3

e6/l

86.4

93.2

0.63

17899

76122

(3006504) Eosinophils/100 leukocytes in Blood

32837

150240

2.12

307.65

8.9

5.5

2.6

2.9

105.78

31294

139788

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

699

734

6.66

307.65

2.3

1.7

—

(3001604) Monocytes [#/volume] in Blood

34328

160515

2.11

307.65

8.5

5.4

e9/l

0.6

260.74

30332

138883

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

3771

10060

2.70

307.65

2.3

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

837

397

14.79

307.65

1.6

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

700

734

6.67

307.65

2.3

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

34531

161665

2.11

307.65

8.7

5.5

umol/l

10.9

11.5

10.02

33065

152543

(3047181) Lactate [Moles/volume] in Blood

3092

8284

2.67

307.65

8.5

4.7

mmol/l

1.3

3.11

2777

7270

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2221

3855

4.10

307.65

3.9

2.7

u/ml

5236.7

5700.3

0.04

159

186

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

3709

12035

2.21

307.65

5.6

3.4

51.1

48.1

10.01

3662

11909

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1740

2202

5.60

307.65

1.9

1.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

11078

39241

2.17

307.65

3.4

2.3

20.9

23.6

65.90

9477

33667

(3009445) Proteinase 3 Ab [Units/volume] in Serum

4455

11872

2.73

307.65

1.7

1.5

u/ml

12.9

14.4

0.29

133

320

(3018405) Lactate [Moles/volume] in Arterial blood

3117

9197

2.42

307.65

5.7

3.7

mmol/l

1.4

0.15

3050

9056

(3024354) Oxygen [Partial pressure] in Venous blood

7120

21070

2.52

307.65

4.8

3.2

kpa

4.8

4.6

4.20

6816

20490

(3008757) Leukocyte morphology finding [Identifier] in Blood

1326

2659

3.51

307.65

4.5

3.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

3342

7157

3.36

307.65

1.3

1.1

—

(3012501) Base excess in Blood by calculation

2632

5848

3.21

307.65

5.8

2.9

mmol/l

2.8

2.3

13.02

1959

3703

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

11544

48494

1.80

307.65

3.6

2.7

e6/l

3.0

0.33

6390

25730

(3007930) Methemoglobin/Hemoglobin.total in Blood

3636

10650

2.45

307.65

7.5

4.2

0.9

0.12

3405

9987

(44790048)

2010

2134

6.71

307.65

1.8

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

19865

100964

1.54

307.65

3.3

2.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

16485

68586

1.91

307.65

2.3

1.7

mg/l

1.4

1.1

13.11

13262

50983

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

5219

14325

2.67

307.65

13.4

8.7

—

(40767503) Oxygen content in Capillary blood by calculation

2446

5466

3.19

307.65

3.3

2.1

16.0

17.0

21.41

1328

2754

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

758

790

6.72

307.65

4.7

3.0

—

(3019198) Lymphocytes [#/volume] in Blood

34975

166159

2.08

307.65

8.6

5.4

e9/l

1.9

2.0

7.67

31355

146510

(3003458) Phosphate [Moles/volume] in Serum or Plasma

11954

36493

2.58

307.65

8.8

5.2

mmol/l

1.1

1.0

17.38

11274

34060

(3023419) Bacteria identified in Sputum by Culture

2274

1960

8.31

307.65

3.0

1.9

—

(1175426) CD3 cells/100 lymphocytes in Blood

1140

2013

3.98

307.65

2.1

2.2

72.6

72.7

0.05

1092

1945

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

21458

98822

1.78

307.65

3.3

2.4

u/l

55.0

58.9

11.78

20120

90872

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1743

2554

4.84

307.65

1.2

1.1

—

(3023368) Bacteria identified in Blood by Culture

28914

67854

4.73

307.65

5.8

3.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

9020

25173

2.74

307.65

5.5

3.7

kpa

5.9

5.8

12.88

8700

24543

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

8704

35156

1.83

307.65

3.4

2.6

umol/l

8.1

8.4

0.46

7502

30420

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

4207

10940

2.79

307.65

2.6

1.7

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

1126

1982

3.99

307.65

2.0

2.2

13.4

13.7

0.28

555

989

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1711

4030

3.00

307.65

3.3

3.0

nmol/l

0.8

4.01

1330

3094

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1730

3099

3.95

307.65

7.4

5.8

mg/l

11.6

11.1

4.16

1583

2870

(3028308) Erythrocytes [#/volume] in Pleural fluid

1447

1968

5.19

307.65

1.5

1.4

e6/l

40865.8

59727.2

1.54

881

1156

(3042631) Mycobacterium sp identified in Specimen

1876

2724

4.89

307.65

3.3

2.1

—

(3006315) Basophils [#/volume] in Blood

34447

161283

2.11

307.65

8.5

5.4

e9/l

0.0

0.24

30458

139469

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

1004

1366

5.16

307.65

1.5

1.4

u/l

12.8

12.3

1.01

962

1333

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2847

7614

2.67

307.65

1.6

1.4

iu/ml

18.8

11.7

1.59

156

(3027801) Oxygen [Partial pressure] in Arterial blood

11193

29090

3.04

307.65

9.8

6.7

kpa

11.0

13.3

307.65

10599

27884

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

14743

55604

2.11

307.65

4.9

3.2

ng/l

439.7

529.2

1.17

11761

39932

(3013650) Neutrophils [#/volume] in Blood by Automated count

37812

186829

2.07

307.65

14.0

8.1

e9/l

4.6

4.0

307.65

33871

162619

(3014576) Chloride [Moles/volume] in Serum or Plasma

10419

35172

2.27

307.65

10.4

6.3

mmol/l

103.9

104.7

47.35

10127

34499

(44790049)

2010

2132

6.72

307.65

1.8

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

6713

16984

2.95

307.65

5.7

3.2

kpa

5.2

5.1

15.06

6283

15682

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

24476

113882

1.82

307.65

4.8

3.0

ng/l

73.0

58.1

0.59

17930

70635

(3021589) Normoblasts [#/volume] in Blood

27455

146289

1.55

307.65

14.4

8.4

e9/l

0.0

0.64

22534

120223

(3003434) Protein [Mass/volume] in Pleural fluid

1770

2371

5.30

307.65

1.5

1.4

g/l

33.0

33.8

1.31

1582

2161

(3005719) IgG [Mass/volume] in Serum or Plasma

7186

22215

2.41

307.65

3.7

2.4

g/l

10.2

10.7

13.15

6672

20252

(3026493) Urate [Moles/volume] in Serum or Plasma

16214

82880

1.48

307.65

3.7

2.3

umol/l

3325.5

4241.6

2.49

14272

72359

(3025159) Blasts/100 leukocytes in Blood

6061

23015

1.92

307.65

5.4

3.9

0.0

0.3

4.58

2213

4659

(3002173) Hemoglobin [Mass/volume] in Arterial blood

8738

24787

2.68

307.65

11.3

7.2

g/l

120.3

122.7

18.94

8431

23886

(3004119) Hemoglobin [Mass/volume] in Venous blood

5112

16520

2.25

307.65

4.9

3.1

g/l

124.8

131.3

67.76

4973

16171

(3009343) pH of Capillary blood

6639

16763

2.96

307.65

5.7

3.2

7.4

0.20

991

1998

(3023199) Leukocytes [#/volume] in Pleural fluid

1597

2162

5.23

307.65

1.5

1.4

e6/l

4453.4

2828.6

1.13

1172

1545

(3035880) pH of Pleural fluid

798

887

6.30

307.65

1.2

1.3

—

(3021901) Oxygen saturation in Capillary blood

2274

4341

3.73

307.65

3.7

2.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1723

1481

8.26

307.65

4.2

3.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1400

1294

7.65

307.65

1.7

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

39456

227354

1.58

307.65

5.7

3.9

—

(3017181) Myelocytes/100 leukocytes in Blood

7150

25062

2.11

307.65

5.2

3.8

1.0

0.9

0.57

2838

5892

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

3382

9524

2.55

307.65

1.8

1.6

titre

347.2

269.9

0.69

150

369

(3027945) Reticulocytes/100 erythrocytes in Blood

9248

30566

2.29

307.65

3.3

2.4

1.9

1.7

37.15

8280

27086

(3011412) CD3 cells [#/volume] in Blood

1448

2481

4.12

307.65

2.5

2.4

e9/l

1.1

1.2

1.01

904

1458

(3026008) Bacteria identified in Urine by Culture

20265

89328

1.86

307.65

3.7

2.8

—

(3032080) INR in Blood by Coagulation assay

27253

119978

2.04

307.65

11.7

7.4

inr

1.3

1.2

7.16

7972

35407

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

4384

11569

2.75

307.65

1.9

1.6

g/l

1.6

1.5

25.64

3799

9842

(3004588) Protein electrophoresis panel - Serum or Plasma

5410

17696

2.23

307.65

3.1

2.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

1356

2825

3.38

307.65

1.4

g/l

0.4

0.25

984

1925

(3002032) Base excess in Venous blood by calculation

9023

25057

2.76

307.65

5.6

3.7

mmol/l

2.1

1.7

22.56

7502

20386

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

879

970

6.35

307.65

2.2

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

3140

7791

2.89

307.65

1.9

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

9885

35867

2.09

307.65

2.2

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

20660

104087

1.57

307.65

4.4

3.1

mmol/l

2.3

2.4

52.81

18348

91107

(3013115) Eosinophils [#/volume] in Blood

35238

166821

2.11

307.65

9.1

5.6

e9/l

0.2

1.18

31518

146524

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

2044

4856

2.98

307.65

1.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3898

12509

2.24

307.65

4.2

2.8

0.7

0.37

3787

11955

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

6459

16182

2.97

307.65

5.6

3.2

mmol/l

2.1

1.4

41.77

5003

11541

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3182

9897

2.29

307.65

3.1

1.9

g/l

7.6

7.3

19.22

2393

7406

(3012544) pH of Venous blood

9269

26067

2.73

307.65

5.6

3.7

7.4

0.01

128

(3000991) Gas panel - Venous blood

8181

23159

2.67

307.65

11.6

7.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

5195

13258

2.87

307.65

6.0

4.3

mmol/l

24.3

24.0

9.53

4741

11931

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

19843

77620

2.15

307.65

3.9

2.7

ng/l

1969.6

1083.4

79.35

17501

64966

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

706

750

6.58

307.65

2.3

1.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2980

9211

2.30

307.65

3.0

2.0

g/l

10.2

0.14

2510

7691

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3179

9885

2.30

307.65

3.1

1.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

7365

29633

1.82

307.65

4.7

2.9

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

30199

136941

2.05

307.65

10.2

5.2

mmol/l

1.2

150.44

28085

123683

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

5549

16976

2.39

307.65

13.1

8.3

1.4

7.32

5506

16876

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

11197

29107

3.04

307.65

9.8

6.7

kpa

5.1

11.63

10614

27898

(44806118)

2010

2133

6.72

307.65

1.8

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

6857

22550

2.25

307.65

3.2

2.5

e9/l

72.0

69.1

6.85

5167

16881

(3028271) Lactate [Moles/volume] in Capillary blood

1878

4042

3.29

307.65

2.3

1.6

mmol/l

1.6

1.8

9.04

1840

3941

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

21705

107255

1.63

307.65

4.2

3.0

u/l

36.2

32.7

2.69

20666

101700

(3012441) Differential panel - Pleural fluid

1364

1859

5.18

307.65

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

2105

1939

7.75

307.65

1.9

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

15220

76684

1.50

307.65

3.2

2.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

2571

2317

7.98

307.65

1.8

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

11949

52420

1.72

307.65

3.4

2.6

e6/l

1.4

1.1

0.70

6766

29478

(3004809) Band form neutrophils/100 leukocytes in Blood

1930

3904

3.50

307.65

3.9

2.9

1.5

1.4

0.64

1539

2978

(3023183) Ammonium ion [Moles/volume] in Plasma

2477

5430

3.25

307.65

2.9

2.8

umol/l

33.2

34.5

1.24

2130

4613

(3008152) Bicarbonate [Moles/volume] in Arterial blood

5854

16082

2.68

307.65

9.9

6.1

mmol/l

25.0

24.4

22.53

5492

14944

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

13692

25690

4.48

307.65

2.2

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1480

1575

6.65

307.65

1.9

1.4

—

(40758558) Short blood count panel - Blood

18140

79829

1.82

307.65

10.2

6.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

878

975

6.31

307.65

2.2

1.6

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

1243

1578

5.55

307.65

1.3

u/l

628.1

383.0

2.42

1179

1495

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

5428

7953

5.09

307.65

2.3

1.8

ug/l

2.3

0.02

4883

6927

(3028626) Oxygen [Partial pressure] in Capillary blood

2959

6456

3.29

307.65

5.4

3.6

kpa

8.2

8.8

54.56

2763

6040

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3172

9869

2.29

307.65

3.1

1.9

g/l

3.9

3.8

0.61

2316

7023

(3022313) Gas panel - Capillary blood

4673

12331

2.76

307.65

6.1

3.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

18662

39021

4.34

307.65

2.3

1.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

3614

9151

2.85

307.65

2.8

2.2

ug/l

618.9

489.1

0.69

3400

8501

(3013290) Carbon dioxide [Partial pressure] in Blood

2633

5849

3.21

307.65

5.8

2.9

kpa

5.1

5.0

5.17

2577

5718

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

3174

2989

7.71

307.65

2.0

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1480

1575

6.65

307.65

1.9

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

2773

2473

8.09

307.65

1.6

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

6605

24091

2.01

307.65

5.4

3.9

0.1

1.32

2627

5462

(3002030) Lymphocytes/100 leukocytes in Blood

33531

156334

2.09

307.65

9.0

5.5

25.2

29.2

307.65

31931

145540

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

3851

3819

7.39

307.65

1.4

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

8863

23546

2.88

307.65

10.9

6.5

mmol/l

10.6

8.8

76.50

8493

22393

(3027135) IgG subclass 1 [Mass/volume] in Serum

1357

2831

3.37

307.65

1.4

g/l

6.7

0.09

982

1923

(3042936) Bacteria identified in Isolate by Culture

12464

40608

2.42

307.65

2.5

1.9

—

(3014007) Fractional oxyhemoglobin in Arterial blood

5577

17026

2.40

307.65

13.2

8.4

92.9

94.4

53.24

5549

16974

(3003396) Base excess in Arterial blood by calculation

11172

29137

3.03

307.65

9.8

6.6

mmol/l

1.6

0.7

68.43

9031

22718

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

19703

92130

1.71

307.65

2.7

2.0

u/l

265.1

199.4

7.30

18625

86421

(3016502) Oxygen saturation in Arterial blood

9867

26242

2.92

307.65

10.4

7.0

94.6

96.2

94.84

9478

25294

(3034860) Kappa light chains.free [Mass/volume] in Serum

2834

7713

2.62

307.65

4.4

2.9

mg/l

61.4

61.2

0.01

2277

6260

(3012095) Magnesium [Moles/volume] in Serum or Plasma

14279

45772

2.52

307.65

5.0

3.1

mmol/l

0.8

30.48

13443

42670

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

3726

10834

2.47

307.65

7.4

4.1

1.8

1.7

7.90

3482

10164

(3022948) Iron [Moles/volume] in Serum or Plasma

12366

46628

2.05

307.65

3.3

2.3

umol/l

11.6

14.3

8.99

11554

43196

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1516

930

11.55

307.65

1.2

1.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

39204

213443

1.77

307.65

5.8

4.0

e6/l

1155.7

1406.5

0.45

697

2711

(3027315) Oxygen [Partial pressure] in Blood

2650

5884

3.22

307.65

5.8

2.9

kpa

8.4

8.9

31.67

2593

5753

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2872

5069

4.07

307.65

7.7

4.5

iu/ml

2758.6

554.3

0.97

502

567

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

4837

6676

5.37

307.65

3.1

2.3

—

(3018572) Chloride [Moles/volume] in Blood

2195

5743

2.71

307.65

9.9

5.5

mmol/l

104.4

105.4

13.72

1981

5171

(4062490)

1363

2829

3.39

307.65

1.4

—

(44790047)

2010

2133

6.72

307.65

1.8

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

3850

3817

7.39

307.65

1.4

1.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

44025

250446

1.80

307.65

11.5

6.6

u/l

82.9

76.8

105.56

42317

235311

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

2553

1977

9.29

307.65

1.5

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

6388

23448

1.99

307.65

2.7

2.2

ug/l

7.7

7.3

0.72

5499

20552

(40760888) Immunoglobulin light chains.free panel - Serum

2244

5638

2.82

307.65

4.5

2.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

3110

4341

5.18

307.65

1.7

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

3912

7637

3.72

307.65

3.8

3.2

u/ml

0.3

0.4

6.80

2326

4219

(3020630) Protein [Mass/volume] in Serum or Plasma

7012

21468

2.43

307.65

3.2

2.3

g/l

65.0

67.2

85.55

6471

19507

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

7566

18946

3.02

307.65

1.9

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

5688

17115

2.44

307.65

2.2

1.8

g/l

1.2

1.3

1.38

5185

15669

(3019069) Monocytes/100 leukocytes in Blood

32991

151112

2.12

307.65

9.3

5.7

8.6

8.5

6.13

31529

141409

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1978

5334

2.62

306.05

1.3

1.2

titre

176.4

103.4

0.70

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2701

8437

2.27

305.34

3.2

2.1

g/l

0.9

0.8

1.22

2341

7255

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

517

480

7.51

303.85

1.2

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1003

1828

3.85

293.08

19.1

18.5

nmol/l

2240.3

2716.7

0.16

961

1748

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

26976

154646

1.38

289.04

5.2

3.7

—

(4010399)

5380

21920

1.77

288.04

1.6

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

2561

8070

2.25

283.24

6.3

3.9

mmol/l

3.9

1.24

2357

7650

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2810

9202

2.17

283.20

1.9

1.6

g/l

0.2

1.62

2664

8736

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

1020

1938

3.69

281.47

2.7

2.5

e6/l

777.4

703.5

0.28

416

738

(3010503) CD19 cells [#/volume] in Blood

866

1463

4.14

279.33

2.7

2.5

e9/l

0.5

0.2

1.18

844

1428

(3052851) Hemolysis interference index of Serum or Plasma

2699

8747

2.19

278.98

4.1

2.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2415

7475

2.29

278.39

2.9

2.0

g/l

0.0

0.83

2218

6837

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2859

9502

2.14

277.55

1.9

1.6

g/l

1.2

1.31

2715

9056

(3015736) pH of Urine

22528

125990

1.38

277.17

4.1

3.1

5.8

0.02

(3008536) Aspergillus sp Ab [Presence] in Serum

409

318

8.96

273.90

2.1

2.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

947

1740

3.81

273.65

13.5

13.3

nmol/l

837.3

1694.0

0.73

919

1677

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2936

9919

2.10

273.26

3.2

2.4

90.9

92.8

4.19

2808

9170

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2452

7723

2.25

271.28

2.8

1.9

g/l

36.3

38.4

49.58

2153

6604

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1644

4303

2.69

269.14

1.6

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

2254

6877

2.32

268.37

2.9

2.0

g/l

0.0

0.29

2061

6264

(40760892) CBC W Ordered Manual Differential panel - Blood

14307

74357

1.44

266.73

6.4

4.0

—

(3035350) Ketones [Presence] in Urine by Test strip

27959

162578

1.35

264.62

4.5

3.3

estimate

0.0

2.93

5828

29656

(3003181) Sodium [Moles/volume] in Urine

1655

4394

2.65

263.58

1.6

1.4

mmol/l

61.7

64.4

1.47

1272

3501

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

23676

134274

1.36

262.40

2.7

2.2

nmol/l

75.1

750.0

0.50

21596

121752

(3026250) Tacrolimus [Mass/volume] in Blood

719

1099

4.57

261.79

40.3

34.6

ug/l

7.4

7.3

0.44

657

1005

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

2217

6788

2.31

261.76

3.0

2.0

g/l

0.0

0.00

2053

6247

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

6645

29424

1.63

260.39

3.9

4.0

ug/l

21.6

25.7

0.52

5492

23211

(3037522) Nuclear Ab [Titer] in Serum

9388

45073

1.52

259.83

1.4

1.3

titre

543.5

537.8

0.10

2054

8738

(40757373) Influenza virus identified in Isolate

385

297

9.03

259.23

1.8

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

701

1062

4.61

257.88

33.5

25.1

ug/l

117.2

121.0

0.54

577

895

(3005322) IgE [Units/volume] in Serum or Plasma

5051

20868

1.74

256.18

1.5

1.3

u/ml

268.0

243.9

0.69

4670

19342

(3009261) Glucose [Presence] in Urine by Test strip

28161

164776

1.34

250.20

4.6

3.4

estimate

0.0

0.63

5753

29637

(3017354) Segmented neutrophils/100 leukocytes in Blood

1114

2461

3.17

245.18

3.9

2.9

60.4

57.0

3.94

742

1557

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

2088

6420

2.30

243.94

1.7

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

2072

6368

2.30

242.29

1.7

1.4

u/ml

20.8

18.1

0.38

103

(3021601) Nitrite [Presence] in Urine by Test strip

27840

163145

1.34

241.37

6.1

4.5

estimate

0.0

1.84

5985

30475

(3036489) Thrombin time

3236

11859

1.94

240.23

2.8

2.1

21.7

21.4

1.71

2910

10189

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2657

9095

2.07

238.27

3.2

2.6

203.7

179.1

33.36

2549

8596

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

52630

341712

1.51

232.18

27.7

10.9

mg/l

32.9

21.1

307.65

47786

261832

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

2463

8314

2.10

228.93

5.3

4.1

mg/l

1.7

1.4

63.40

2283

7702

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

789

1450

3.80

227.88

2.8

2.7

38.0

40.4

1.59

294

455

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5551

24394

1.63

221.91

5.9

3.3

mmol/l

1.2

21.29

5070

21074

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

1210

2998

2.83

219.01

2.0

ug/l

22.4

25.7

1.09

1183

2937

(3020682) Albumin/Creatinine [Ratio] in Urine

17097

94166

1.36

217.04

4.6

3.9

mg/mmol

15.9

8.0

40.50

11558

59149

(3028433) Virus identified in Specimen by Culture

536

750

4.98

215.52

1.2

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

17889

99340

1.35

214.80

3.8

3.2

mmol/l

7.3

8.0

5.27

15233

84022

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1901

5944

2.25

213.25

1.7

1.4

u/ml

116.9

109.2

0.91

376

1368

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1466

4087

2.52

211.50

1.8

1.6

—

(3012516) Albumin [Mass/volume] in Urine

16323

89572

1.36

210.82

3.8

3.2

mg/l

615.3

368.1

7.10

11223

55977

(3019977) pH of Arterial blood

695

1233

3.94

210.43

2.9

2.4

7.4

0.83

237

420

(3017143) Hepatitis C virus Ab [Presence] in Serum

8454

41322

1.48

210.04

1.9

1.6

—

(4035726)

5841

26410

1.59

206.97

1.5

1.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

430

512

5.85

203.74

1.3

mmol/l

3.4

3.6

0.48

388

476

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

2000

6543

2.16

200.93

1.4

1.3

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

1871

6060

2.17

192.61

3.9

3.2

e9/l

4.6

3.9

24.25

1866

6049

(3007164) IgA [Mass/volume] in Serum or Plasma

12466

66371

1.38

191.12

1.8

1.4

g/l

2.5

2.3

11.99

8096

40292

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1888

6167

2.16

190.30

1.4

1.3

u/ml

289.6

251.6

5.83

1227

3922

(1761868) Lipid panel - Serum or Plasma

15077

129046

0.75

190.07

2.9

2.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

297

247

8.36

189.76

2.4

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2298

8104

2.00

189.35

2.1

mg/l

11.7

10.5

4.00

2152

7577

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

745

1501

3.47

188.89

1.5

1.3

—

(3006245) CD3-CD19+ cells/100 cells in Blood

615

1087

3.95

187.14

2.2

2.5

11.3

10.8

0.26

566

1026

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

732

1474

3.47

185.75

1.5

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

456

635

5.00

184.35

1.3

1.4

55.6

65.6

5.51

369

528

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

977

2367

2.89

183.97

3.4

2.5

—

(3042733) HLA Ab [Presence] in Serum

543

886

4.27

182.91

5.1

4.8

—

(3000492) Spirometry study

6703

32128

1.50

180.95

1.7

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3261

13079

1.77

180.88

2.1

2.0

u/l

38.5

39.8

2.97

2892

11716

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

889

2067

3.01

179.73

1.5

1.2

u/ml

1.5

0.9

1.13

531

745

(46235355) HIV 1 and 2 tests - Meaningful Use set

12761

68777

1.36

179.41

2.0

1.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

12156

65087

1.37

177.94

1.8

1.6

pmol/l

29244242.1

35115891.6

0.53

10156

54261

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

594

1063

3.90

177.82

2.0

2.4

30.0

28.1

1.91

558

1019

(4015189)

401

513

5.44

177.13

3.0

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

13821

75598

1.34

175.90

4.2

3.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

600

1094

3.83

175.18

3.9

2.9

—

(3017569) Oxygen content in Arterial blood

563

986

3.98

173.41

2.1

—

(21494755) Public health laboratory ask at order entry panel

3671

40096

0.61

171.14

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1521

4756

2.25

170.27

1.2

—

(3016228) CD19 cells/100 cells in Blood

555

984

3.93

168.22

2.1

2.0

8.7

8.4

0.16

543

960

(3013512) EKG study

15763

88558

1.31

164.56

4.7

3.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

543

965

3.92

164.08

2.1

2.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

217

142

10.62

162.45

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2558

9872

1.83

160.68

1.6

iu/ml

2.8

6.8

0.65

605

2004

(3040151) Glucose [Moles/volume] in Capillary blood

1104

3072

2.52

159.70

16.0

4.5

mmol/l

7.4

7.3

0.69

942

2472

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

338

405

5.81

159.27

1.4

26.5

19.9

2.79

274

351

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

275

266

7.19

156.55

1.4

1.1

—

24.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

459

743

4.30

156.18

2.1

1.9

—

(3037121) Protein [Mass/volume] in Urine

2607

10252

1.80

153.91

3.9

3.2

g/l

0.4

0.3

2.95

1384

4488

(3048929) Epstein Barr virus Ab [Presence] in Serum

2773

11162

1.76

151.26

1.4

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1836

6477

1.99

150.70

1.6

1.3

—

(3046861) Legionella sp Ag [Presence] in Urine

140

23.70

149.67

1.1

1.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5486

26232

1.49

147.83

1.6

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2265

8664

1.84

146.12

1.2

—

(3019230) Fractional oxyhemoglobin in Venous blood

1481

4898

2.12

144.34

4.7

3.3

64.9

65.0

0.08

1473

4880

(3019550) Sodium [Moles/volume] in Serum or Plasma

52353

344905

1.38

144.01

29.6

12.6

mmol/l

139.2

139.7

307.65

51409

335868

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3307

35650

0.62

143.75

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

544

1071

3.54

142.73

2.2

1.8

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

563

1140

3.44

141.76

1.6

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

562

1140

3.44

141.13

1.6

1.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

178

109

11.34

138.57

1.9

1.7

umol/l

48.1

43.6

0.71

178

109

(3045142) Bone marrow Pathology biopsy report

999

2839

2.46

138.29

1.5

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

52436

345976

1.37

137.61

29.8

12.7

mmol/l

4.0

37.94

51399

336250

(3001964) Herpes simplex virus Ag [Presence] in Specimen

439

766

3.99

135.95

1.9

1.3

—

(3017704) Immunofixation for Urine

579

1231

3.28

135.39

1.9

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

192

139

9.59

134.99

1.1

1.2

—

(3024471) HLA-A [Type]

490

937

3.64

134.05

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2364

9407

1.77

133.81

1.3

—

(3013727) Leukocytes other/100 leukocytes in Blood

427

741

4.01

133.19

4.3

3.0

55.0

50.5

3.11

417

715

(21494890) Protein electrophoresis panel - 24 hour Urine

927

2591

2.50

132.85

2.6

1.9

—

(3024932) HLA-DR beta [Type]

481

915

3.66

132.56

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

877

2398

2.56

131.45

1.2

titre

235.5

163.1

0.44

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

878

2405

2.55

131.13

1.2

titre

177.9

193.1

0.20

144

402

(3000060) B lymphocytes [#/volume] in Blood

458

848

3.76

131.05

2.0

2.5

e6/l

684.4

580.3

0.10

270

459

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3570

15934

1.59

130.84

3.5

2.5

e6/l

0.3

1.93

3491

15463

(3001893) Eosinophils/100 leukocytes in Pleural fluid

366

570

4.47

130.53

1.3

1.4

2.9

2.8

0.09

306

481

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

431

772

3.89

128.98

3.3

2.9

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

340

506

4.67

127.83

1.3

ug/l

145.3

379.4

1.49

190

260

(40768446) Kidney Pathology biopsy report

526

1092

3.36

127.61

1.8

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

568

1240

3.19

127.42

1.3

1.1

—

(3051651) Icteric interference index of Serum or Plasma

674

1633

2.88

126.93

4.9

3.5

—

(3008295) Osmolality of Serum or Plasma

944

2731

2.42

125.81

1.4

1.6

mosm/kgh2o

278.8

280.7

1.34

724

2145

(3044889) 12 lead EKG panel

36049

228080

1.23

124.26

4.5

3.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

760

1994

2.66

123.57

2.4

1.7

mg/l

4.7

3.3

8.80

721

1902

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

253

293

6.00

123.22

1.7

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1331

4492

2.08

123.00

1.3

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

15188

87531

1.27

122.44

5.2

3.7

estimate

0.0

1.66

5558

29518

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

6363

58711

0.72

120.92

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2196

8811

1.75

120.64

1.4

ug/g

259.8

281.8

4.93

1300

4997

(3017817) Protein [Mass] in Urine collected for unspecified duration

860

2437

2.46

119.78

2.6

2.5

0.2

0.7

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

576

1322

3.04

119.09

1.2

1.1

iu/ml

4.2

3.8

0.26

111

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

281

375

5.21

119.01

1.3

1.4

ng/l

112.1

334.5

0.41

207

210

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

635

1544

2.87

118.86

2.6

2.5

u/ml

1310.1

891.4

2.77

626

1529

(3035637) Corticotropin [Mass/volume] in Plasma

1187

3891

2.13

118.23

1.6

1.5

—

(3025941) Bacteria identified in Stool by Culture

4072

19145

1.51

117.74

1.4

1.2

—

(40768797) Stomach Pathology biopsy report

8238

43921

1.35

117.68

1.3

1.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

432

834

3.61

116.66

7.0

5.7

mmol/l

25.1

0.00

385

766

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

369

641

4.01

115.02

1.3

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

326

521

4.35

112.80

1.3

1.4

27.1

18.3

5.17

296

472

(3020191) Ethanol [Moles/volume] in Serum or Plasma

880

2596

2.37

112.41

1.8

1.4

promille

1.3

1.4

0.78

678

2001

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2132

24116

0.60

111.84

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

546

1261

3.02

111.74

2.1

2.0

umol/l

127.3

143.1

0.43

265

645

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1017

3217

2.21

110.61

1.3

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1047

3356

2.18

110.26

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

153

108

9.83

109.39

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

788

2243

2.45

108.74

2.1

1.9

g/24h

1.3

0.9

0.58

139

(3014891) Appearance of Pleural fluid

196

6.94

108.69

1.7

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

16426

96571

1.24

108.59

4.4

4.7

ug/l

3.3

3.0

0.54

14680

87331

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

191

192

6.91

105.47

1.6

1.7

mg/l

2.0

1.4

0.60

126

127

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1320

4701

1.97

105.25

1.1

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

188

186

7.02

105.19

1.6

1.7

mg/l

3.5

4.1

0.48

124

116

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

188

186

7.02

105.19

1.6

1.7

mg/l

1.8

1.6

0.27

136

132

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

188

186

7.02

105.19

1.6

1.7

mg/l

2.4

2.9

0.36

129

131

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

188

186

7.02

105.19

1.6

1.7

mg/l

2.8

2.6

0.10

132

135

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

188

186

7.02

105.19

1.6

1.7

mg/l

1.2

1.3

0.09

125

112

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

188

186

7.02

105.19

1.6

1.7

mg/l

1.5

2.2

0.84

115

112

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

188

186

7.02

105.19

1.6

1.7

mg/l

1.2

0.7

0.81

122

128

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

188

186

7.02

105.19

1.6

1.7

mg/l

2.1

2.2

0.05

125

124

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

188

186

7.02

105.19

1.6

1.7

mg/l

2.1

0.03

141

137

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

526

1232

2.97

105.14

1.8

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

526

1233

2.97

104.99

1.8

1.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

154

117

9.14

104.94

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

475

1052

3.14

104.21

2.8

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

441

934

3.29

103.85

2.5

2.0

ug/l

61.6

63.8

0.20

434

910

(3052592) Norovirus Ag [Presence] in Stool

278

417

4.63

103.68

1.5

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1085

3617

2.10

103.51

2.4

2.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1920

7775

1.73

101.94

1.5

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

371

712

3.62

101.11

3.3

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

371

712

3.62

101.11

3.3

2.2

—

(3044927) Protein electrophoresis panel - Urine

810

2420

2.34

100.61

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

282

442

4.43

99.93

5.9

5.8

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

712

2012

2.47

99.79

1.3

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

131

10.69

98.67

2.0

1.2

—

(3045716) Anion gap in Serum or Plasma

490

1145

2.98

98.37

2.7

2.3

mmol/l

8.8

9.4

2.52

367

823

(3019225) pH of Specimen

5773

29885

1.37

98.17

6.5

3.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

948

3062

2.16

97.98

1.3

1.2

u/l

72.7

65.4

0.55

710

1995

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

259

386

4.66

97.34

3.3

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

858

2668

2.24

97.22

1.2

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

257

382

4.67

96.89

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

898

2859

2.19

96.16

1.6

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

944

3070

2.15

95.92

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1111

3862

2.01

94.79

1.7

1.3

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

187

211

6.15

93.40

1.3

u/l

305.6

195.7

0.19

129

159

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

20868

127189

1.21

93.35

4.9

3.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1087

3770

2.02

93.32

1.7

1.3

—

(3008037) Lactate [Moles/volume] in Venous blood

1544

6034

1.79

92.51

4.6

2.7

mmol/l

1.6

0.15

1509

5912

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1074

3729

2.01

91.93

1.7

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1285

4749

1.89

91.88

1.2

—

(44786800) Granulocytes/100 leukocytes in Body fluid

178

194

6.37

91.73

1.3

31.7

18.8

3.60

139

145

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1072

3726

2.01

91.49

1.7

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1071

3724

2.01

91.31

1.7

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1080

3770

2.00

91.09

1.7

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

191

228

5.82

90.52

1.2

—

(21494434) Karyotype in Bone marrow

741

2235

2.31

90.12

1.2

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1405

5383

1.83

89.79

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1735

7075

1.72

89.77

1.7

1.6

e6/l

16840.2

12311.9

2.42

1287

5127

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2329

10266

1.59

89.18

3.4

3.5

u/ml

960.9

2019.6

0.80

1992

8819

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

1010

3472

2.03

88.84

2.6

2.0

32.1

32.8

5.56

1000

3448

(3021788) Differential panel - Synovial fluid

1395

5358

1.82

88.44

1.6

1.5

—

(3041354) Potassium [Moles/volume] in Venous blood

957

3238

2.06

87.84

3.2

2.0

mmol/l

4.1

4.0

0.58

946

3218

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1198

4395

1.91

87.58

1.3

u/l

61.5

27.3

7.25

1048

3845

(3035285) Chloride [Moles/volume] in Venous blood

956

3237

2.06

87.57

3.2

2.0

mmol/l

105.1

105.8

4.52

945

3216

(40761536) Microorganisms panel - Urine sediment

5364

27931

1.36

87.30

5.3

3.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2453

11013

1.57

86.82

1.5

1.3

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

175

201

6.04

86.02

1.4

1.3

66.2

76.3

2.70

142

175

(3016038) Potassium [Moles/volume] in Urine

617

1753

2.45

85.56

1.4

1.3

mmol/l

31.9

35.2

2.95

527

1526

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1380

5342

1.81

85.29

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

2053

8872

1.62

85.20

1.2

titre

812.3

954.3

0.41

251

(3041918) Cholesterol [Moles/volume] in Pleural fluid

232

354

4.55

84.93

1.3

1.2

mmol/l

1.7

1.8

0.34

157

196

(3007566) Smooth muscle Ab [Titer] in Serum

2083

9042

1.62

84.90

1.2

1.3

titre

109.3

121.3

0.37

204

814

(40761535) Cells panel - Urine sediment

4906

25294

1.37

84.84

4.4

3.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

36062

232070

1.19

84.10

4.1

2.9

u/l

59.7

44.4

124.62

33947

218011

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

164

181

6.29

83.61

1.3

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

898

3025

2.07

83.40

4.7

3.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

593

1688

2.45

81.93

1.3

1.2

u/l

112.0

82.9

5.66

537

1465

(3033705) Calcium.ionized [Moles/volume] in Venous blood

928

3192

2.03

81.51

3.3

2.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

471

1204

2.72

80.63

7.2

4.4

mg/l

1526.6

2920.7

0.78

370

845

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

46276

334589

0.82

80.46

4.5

4.1

mmol/l

1.4

1.5

248.78

42775

311585

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1816

19771

0.62

80.01

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

575

1640

2.44

79.13

1.3

1.2

u/l

35.6

19.8

6.40

514

1399

(3017732) Neutrophils [#/volume] in Blood

4425

22757

1.37

77.38

3.8

2.5

e9/l

4.6

4.0

29.39

3420

17889

(3042010) Triglyceride [Moles/volume] in Pleural fluid

196

281

4.84

77.05

1.3

1.2

mmol/l

0.7

2.0

2.38

125

175

(3038515) Glucose [Moles/volume] in Venous blood

1416

5700

1.74

76.65

4.9

2.7

mmol/l

7.8

7.5

3.10

1388

5599

(3019150) Specific gravity of Urine by Refractometry

12215

71708

1.23

76.51

5.0

3.7

kg/l

1.0

0.58

1893

10679

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

194

278

4.85

76.31

1.5

u/ml

63.4

54.5

—

(3004451) EKG impression Narrative

464

1213

2.66

76.15

1.4

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2212

9992

1.55

76.07

2.1

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1385

5559

1.74

75.74

4.9

2.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

389

927

2.92

75.63

1.4

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

167

210

5.52

75.32

4.3

4.5

mg/l

2.2

2.3

0.28

145

181

(42529406) Shigella sp [Presence] in Stool by Culture

2113

9482

1.56

74.79

1.3

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2107

9454

1.56

74.62

1.3

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

7942

44567

1.27

74.32

2.1

1.7

1.6

1.4

57.09

6909

39690

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2090

9369

1.56

74.31

1.3

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

9923

57161

1.24

73.93

1.8

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

46731

336934

0.83

73.16

4.5

4.2

mmol/l

4.5

4.7

286.48

43390

315065

(3001019) Free T4 and TSH panel - Serum or Plasma

1918

20217

0.65

72.67

1.7

1.6

—

(40762365) Oxygen content in Arterial blood by calculation

219

367

4.14

71.68

3.0

ml/dl

14.9

14.8

0.11

204

341

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2707

12937

1.47

71.20

1.3

1.2

u/ml

1.0

0.8

0.30

217

1134

(3047189) Immunofixation for 24 hour Urine

421

1087

2.69

70.80

2.2

1.7

—

(3044941) Cell count panel - Synovial fluid

1162

4521

1.80

70.63

1.5

1.4

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

169

230

5.10

70.32

3.7

2.5

mg/l

1.1

1.5

0.85

117

155

(3014271) Vancomycin [Susceptibility]

449

1203

2.60

70.29

3.3

2.7

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1845

8141

1.59

70.17

1.4

mg/l

580.5

523.6

1.32

1747

7784

(3013005) Retinol [Moles/volume] in Serum or Plasma

483

1345

2.50

69.95

2.1

2.0

umol/l

1.9

0.17

458

1265

(3041096) Erythrocytes [Presence] in Urine by Automated

14933

90135

1.20

68.71

4.3

2.9

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

305

667

3.18

68.49

2.0

1.9

u/l

45.9

33.3

0.62

281

593

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

185

280

4.59

68.47

1.4

12.9

12.2

0.10

140

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1245

4995

1.74

68.18

1.3

1.2

u/ml

4.3

3.9

0.65

596

2209

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1103

4285

1.80

67.39

1.1

g/l

1.6

1.5

9.16

1015

3878

(3044290) Cell count panel - Cerebral spinal fluid

1558

6742

1.62

64.20

1.6

1.4

—

(4198724)

549

1689

2.26

63.95

2.4

2.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

601

1924

2.17

63.65

2.2

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1256

5177

1.69

62.45

1.3

1.2

u/ml

4.8

3.5

0.88

448

1780

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1629

7189

1.59

61.88

1.4

1.3

mmol/l

3.9

3.7

6.71

1514

6777

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

606

1969

2.14

61.87

13.4

11.7

mmol/l

0.6

2.08

557

1816

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1629

7199

1.58

61.51

1.6

1.5

e6/l

1385.2

2244.8

0.60

1350

5805

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

746

2632

1.97

61.18

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1625

7196

1.58

60.83

1.6

1.4

e6/l

34.0

30.0

0.20

1280

5519

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

47668

341903

0.84

60.39

5.0

4.6

mmol/l

2.6

2.8

277.20

44023

317853

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

292

673

3.01

60.24

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

560

1792

2.18

59.40

1.7

1.5

u/l

6.6

6.3

0.13

322

823

(3032057) Clostridioides difficile [Presence] in Stool

236

484

3.39

58.64

2.0

1.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

750

2692

1.94

58.57

1.3

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

903

3449

1.83

58.34

1.8

1.5

iu/ml

38.0

32.0

0.39

144

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

620

2086

2.07

57.91

1.4

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

459

1382

2.31

56.26

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1249

5303

1.64

55.52

1.1

au/ml

12.5

12.1

0.04

375

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1086

12229

0.61

54.89

1.4

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1185

13073

0.62

54.88

1.5

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

586

1977

2.06

54.37

2.6

2.2

97.8

97.7

0.02

568

1830

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1480

6586

1.57

54.25

1.2

u/ml

11.1

15.7

0.30

(3029634) Reagin Ab [Titer] in Serum by VDRL

1160

4877

1.66

53.57

2.4

2.1

titre

7.8

6.7

0.09

152

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

273

655

2.90

52.64

11.3

7.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1334

5838

1.60

52.49

3.4

3.3

u/ml

550.8

864.0

0.84

1199

5300

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

36010

235537

1.14

52.24

3.4

3.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

895

3532

1.77

51.95

1.2

1.1

93.6

96.6

2.42

851

3301

(3000963) Hemoglobin [Mass/volume] in Blood

54760

386796

0.80

51.52

37.3

17.0

g/l

131.7

136.8

307.65

54146

381715

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

382

1103

2.41

51.42

2.6

2.4

nmol/l

149.3

150.4

0.06

334

947

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

523

1727

2.11

51.35

1.2

—

(3048879) Bone marrow aspiration report

282

699

2.80

51.33

2.2

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4668

25614

1.28

51.04

3.5

2.4

ml/min/173m2

61.1

69.1

25.53

2042

9744

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

673

2445

1.92

50.80

1.3

1.2

mmol/l

2.2

2.0

3.46

620

2273

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

924

3706

1.74

50.73

1.7

1.5

60.5

55.0

3.81

603

2350

(3010813) Leukocytes [#/volume] in Blood

54765

386740

0.80

50.25

37.1

16.9

e9/l

7.4

6.6

307.65

53567

375658

(3026361) Erythrocytes [#/volume] in Blood

54754

386661

0.80

50.11

37.0

16.9

e12/l

4.4

4.5

307.65

53560

375572

(3024731) MCV [Entitic volume]

54750

386622

0.80

49.91

36.9

16.8

91.0

90.6

82.80

54143

381469

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

384

1129

2.36

49.71

2.6

2.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1115

4735

1.64

49.55

1.1

—

(3035941) MCH [Entitic mass]

54748

386578

0.80

49.47

36.8

16.8

30.2

7.11

54137

381443

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

395

1181

2.32

49.27

1.1

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

133

202

4.57

49.17

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1138

4871

1.63

49.03

1.2

1.1

116.8

118.3

0.71

1062

4386

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

252

604

2.90

48.73

1.4

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

12638

77021

1.17

48.68

3.9

4.1

21.9

0.03

5543

35710

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

504

1682

2.08

48.19

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

354

1018

2.42

48.11

3.0

2.8

umol/l

29.2

28.4

0.53

250

792

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

496

1648

2.09

47.97

1.1

—

(4306422)

1167

5054

1.61

47.97

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

907

3679

1.72

47.88

1.2

1.1

iu/ml

2.3

1.8

0.36

(3036048) Francisella tularensis Ab [Titer] in Serum

262

653

2.79

47.26

1.1

1.2

titre

180.0

615.3

0.80

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

401

1239

2.25

46.41

1.1

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

856

9804

0.60

46.35

1.5

—

(3007461) Platelets [#/volume] in Blood

54735

386255

0.81

46.12

37.1

16.9

e9/l

255.6

252.9

14.78

53685

376208

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

761

8958

0.58

45.94

1.8

—

(3028707) Methadone [Presence] in Urine by Screen method

1476

6817

1.51

45.76

4.1

2.8

—

(3049717) Cytology report of Urine Cyto stain

2180

10863

1.40

45.48

2.5

2.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

101

128

5.47

45.37

1.1

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1553

7267

1.49

45.22

2.7

2.3

ug/min

139.2

104.1

2.07

961

4314

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

213

484

3.06

45.16

2.6

2.5

mg/l

76.4

39.0

1.21

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

45028

322800

0.87

44.94

4.1

3.7

mmol/l

1.4

1.3

140.31

41381

299121

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

449

1490

2.10

43.62

1.8

1.5

iu/ml

2266613.7

1740023.0

0.29

114

(3026389) Candida sp identified in Specimen by Organism specific culture

1073

4671

1.60

43.21

1.4

1.3

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

113

167

4.69

43.16

1.1

mg/l

10.9

8.5

1.07

107

152

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1441

6708

1.50

43.04

1.3

1.2

u/ml

4.8

5.7

0.23

117

479

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

157

303

3.60

42.79

4.0

2.7

umol/l

38.6

43.1

1.52

136

258

(3002385) Erythrocyte distribution width [Ratio]

43319

288421

1.14

42.24

30.7

13.8

14.0

13.5

307.65

42655

282310

(4268621)

830

3413

1.69

41.75

2.4

2.3

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

127

213

4.14

41.75

1.1

u/l

19.3

21.8

0.65

134

(3011544) Albumin [Mass/volume] in Pleural fluid

114

175

4.52

41.70

1.1

1.2

g/l

17.2

17.8

0.29

106

151

(40757494) Bilirubin.total [Moles/volume] in Blood

455

1545

2.05

41.65

2.4

2.1

umol/l

40.7

47.0

0.25

154

(43055442) Apixaban [Mass/volume] in Serum or Plasma

148

280

3.67

41.50

1.5

ug/l

115.5

113.6

0.06

120

223

(3014148) Varicella zoster virus Ab [Titer] in Serum

1036

4521

1.60

41.32

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1587

7594

1.46

41.31

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

223

553

2.80

40.69

1.6

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

616

7424

0.57

40.68

1.5

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

314

928

2.35

40.31

2.3

1.9

e6/l

3254.0

3571.0

0.04

215

628

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3873

21365

1.27

40.23

3.2

3.4

pmol/l

4.4

4.5

19.61

3408

19150

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

470

1638

1.99

40.10

1.7

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1590

7656

1.45

40.07

1.3

1.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

181

402

3.12

39.91

5.6

4.8

ug/min

49.5

44.6

0.44

152

304

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

129

5.11

39.82

5.6

5.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

956

10279

0.64

39.38

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

959

10300

0.64

39.31

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

960

10304

0.64

39.23

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1709

8376

1.43

39.15

1.3

u/ml

8.2

9.1

0.23

296

1253

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

167

357

3.25

39.14

3.3

2.9

—

(3033799) Differential panel - Peritoneal fluid

279

792

2.45

39.10

2.2

1.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1130

5099

1.54

39.03

1.2

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

955

10245

0.64

38.93

1.4

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

196

465

2.93

38.71

3.6

2.2

mmol/l

1.2

0.43

186

444

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1685

8260

1.42

38.56

1.3

u/ml

7.3

6.4

0.18

200

812

(3038071) Oxygen [Partial pressure] in Mixed venous blood

228

590

2.68

38.48

11.3

7.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

5920

48577

0.83

38.45

2.2

2.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1826

9097

1.40

38.13

1.3

u/ml

37.2

35.8

0.09

123

523

(3012565) Volume of 24 hour Urine

435

1503

2.01

38.04

2.4

2.1

1870.4

2019.6

1.73

384

1352

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

9579

58123

1.17

37.58

1.3

iu/ml

40.9

34.0

2.39

3034

17965

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

119

207

3.99

37.40

2.7

3.0

—

(40768795) Lymph node Pathology biopsy report

717

2921

1.71

37.38

1.3

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

599

2317

1.80

37.34

2.1

1.6

—

(3034988) Calcium [Moles/volume] in Capillary blood

203

504

2.80

37.02

3.8

2.4

mmol/l

1.2

0.09

193

483

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1050

10917

0.66

36.83

1.5

—

(3022621) pH of Urine by Test strip

3747

20823

1.26

36.50

3.4

2.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

182

430

2.94

36.25

1.4

1.2

—

(3025315) Body weight

118

209

3.92

36.24

5.6

3.9

—

(3000012) Reticulocyte production index

430

1512

1.98

35.85

1.7

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

551

2107

1.82

35.68

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

980

4371

1.56

35.68

2.7

2.9

u/ml

246.2

818.5

1.26

948

4167

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1363

6528

1.46

35.35

1.5

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

551

2120

1.81

34.99

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

232

637

2.53

34.91

1.4

g/l

14.8

12.9

2.26

175

478

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

668

2725

1.71

34.70

1.4

1.3

nmol/l

1.5

1.4

0.80

612

2457

(3016750) Collection duration of Urine

463

1690

1.90

34.66

2.4

2.1

min

496.1

500.8

0.41

327

1277

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

276

825

2.32

34.64

2.1

1.8

e6/l

9050.5

12258.5

0.34

143

444

(3020393) Adenovirus Ag [Presence] in Stool

165

379

3.02

34.50

1.6

1.3

—

(3003129) Base excess in Capillary blood by calculation

240

675

2.47

34.38

2.0

1.6

mmol/l

1.2

0.3

3.07

226

635

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

512

1943

1.83

34.01

1.7

1.5

u/ml

31.7

22.2

2.43

374

(3006922) Hepatitis E virus Ab [Presence] in Serum

585

2312

1.76

33.99

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

207

545

2.64

33.87

1.3

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

483

1802

1.86

33.85

1.6

1.4

u/l

6.5

5.8

0.57

399

1523

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

298

936

2.21

33.36

1.2

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

928

4156

1.55

33.22

2.1

1.8

titre

2202.6

4327.6

1.34

180

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

105

184

3.96

32.75

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

243

705

2.39

32.62

1.3

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

525

2039

1.79

32.38

1.6

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5397

44018

0.83

32.33

2.1

2.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

442

1627

1.89

32.31

1.4

1.6

nmol/l

1.3

1.2

0.68

338

1293

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1252

12266

0.70

31.96

1.5

1.4

—

(3000330) Specific gravity of Urine by Test strip

2788

15186

1.28

31.92

4.3

3.1

—

(3034426) Prothrombin time (PT)

324

1075

2.09

31.68

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

452

1691

1.86

31.45

1.2

1.3

titre

201.7

487.1

1.70

106

(3004775) Volume in Urine collected for unspecified duration

573

2305

1.73

31.35

2.5

2.2

714.4

673.2

1.30

389

1589

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

441

1645

1.86

30.98

1.2

1.3

titre

79.0

76.5

0.05

150

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

674

2846

1.65

30.82

1.6

1.5

25.6

33.1

6.32

417

1786

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

610

2516

1.69

30.50

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

614

2540

1.68

30.37

1.2

—

(3044007) Cell count panel - Peritoneal fluid

247

746

2.30

30.37

2.4

1.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

609

2514

1.68

30.36

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

608

2511

1.68

30.26

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

810

3602

1.56

29.96

1.6

1.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

110

4.79

29.84

1.8

1.3

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

136

304

3.10

29.82

8.1

7.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

611

2537

1.67

29.81

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

611

2539

1.67

29.73

1.2

—

(3005033) Fetal Nuchal fold Thickness US

791

8336

0.65

29.68

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

411

1526

1.87

29.32

1.2

1.1

u/l

90.2

84.6

0.66

327

1221

(3047352) Trisomy 18 risk [Likelihood] in Fetus

795

8346

0.66

29.29

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

411

1527

1.87

29.27

1.2

1.1

u/l

30.5

23.4

1.45

310

1181

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

370

1328

1.94

29.21

2.6

2.4

umol/l

57.6

52.9

1.92

295

1114

(3043238) Trisomy 21 risk [Likelihood] in Fetus

819

8535

0.66

29.10

1.5

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

201

569

2.45

28.51

1.5

1.3

g/l

34.0

26.0

0.59

157

438

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

238

728

2.27

28.46

1.2

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

1479

7486

1.38

28.16

5.1

3.7

—

(3022145) Colonoscopy Study observation

6198

37101

1.17

28.10

1.4

1.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

371

1352

1.91

28.04

2.4

1.9

umol/l

27.4

28.8

1.61

357

1312

(3044416) Complement C4 [Mass/volume] in Pleural fluid

5.28

27.89

1.1

1.2

g/l

0.1

0.24

(3010144) Erythrocytes [#/volume] in Synovial fluid

647

2786

1.61

27.44

1.5

1.4

e6/l

128312.9

100915.5

0.45

436

1932

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3258

27466

0.81

27.30

2.1

2.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

8895

54824

1.14

27.18

1.3

u/ml

16.6

10.5

4.91

3098

21872

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2896

16160

1.25

27.10

2.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

206

606

2.36

26.94

1.4

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

206

607

2.35

26.84

1.4

1.1

—

(40765096) Chromosome analysis panel by Banding

242

765

2.20

26.81

1.2

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

299

1029

2.02

26.63

1.3

1.2

g/l

0.5

0.6

0.07

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

205

606

2.35

26.53

1.4

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1297

6493

1.39

26.41

3.1

1.9

nmol/l

1.0

0.8

7.58

1067

5478

(40768804) Tissue Pathology biopsy report

20840

135208

1.10

25.87

2.2

2.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

145

366

2.75

25.84

10.3

9.3

umol/l

0.3

0.4

0.46

132

330

(3023410) Appearance of Cerebral spinal fluid

746

3375

1.54

25.65

1.8

1.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

287

996

2.00

25.03

1.3

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

170

3.63

24.83

8.2

3.8

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

177

3.56

24.75

3.1

2.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

121

4.18

24.54

3.9

4.1

—

(3009871) Measles virus Ab [Titer] in Serum

306

1096

1.94

24.42

1.6

1.7

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

6.51

24.41

5.9

4.7

mg/l

8.1

5.7

0.39

(3004616) Nuclear Ab [Presence] in Serum

831

3890

1.49

24.35

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

804

3739

1.50

24.33

2.5

1.9

mg/l

28.4

25.2

0.82

262

953

(3020717) Zinc [Moles/volume] in Serum or Plasma

416

1647

1.75

24.21

1.9

1.5

umol/l

19.2

25.8

5.39

398

1569

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

241

794

2.11

24.15

1.1

—

(3036603) Volume of Urine

498

2076

1.67

24.07

1.8

1.6

1847.8

1964.0

0.63

124

446

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.72

24.04

1.9

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

115

4.22

23.80

1.1

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

118

4.17

23.80

3.8

4.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

134

3.93

23.64

4.3

3.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

423

1697

1.73

23.53

1.2

u/l

286.8

323.9

0.33

389

1589

(3039162) Centromere protein B Ab [Units/volume] in Serum

862

4102

1.46

23.28

1.3

1.2

u/ml

55.0

51.1

0.17

248

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

416

1668

1.73

23.20

1.9

1.7

u/field

2.4

0.02

309

1200

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

236

784

2.09

23.18

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

399

1582

1.75

23.13

1.5

1.2

59.4

65.6

0.66

168

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

122

299

2.83

23.00

1.3

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

131

3.92

22.91

10.0

9.9

e6/l

297.1

278.4

0.04

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1519

13720

0.76

22.81

1.9

1.6

mg/l

5.6

3.2

8.02

1196

9436

(3019768) Coxiella burnetii Ab [Presence] in Serum

151

3.67

22.73

1.2

1.1

—

(3002256) Pathology report gross observation

6979

42785

1.15

22.71

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

236

791

2.07

22.66

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2590

21938

0.81

22.62

1.9

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

4.95

22.47

1.1

g/l

0.2

0.05

(3024263) Appearance of Synovial fluid

384

1521

1.75

22.36

1.7

1.8

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

758

3548

1.49

22.27

1.4

1.3

nmol/l

19.0

33.3

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

191

3.30

22.17

1.6

2.0

ug/g

183.8

173.0

0.23

166

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

158

452

2.42

22.06

1.2

1.1

pmol/l

3.9

7.0

0.37

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

535

2323

1.60

22.06

1.3

1.2

u/ml

11.3

8.6

0.17

160

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

368

1451

1.76

21.79

2.3

2.2

ug/l

23.1

197.6

1.62

355

1377

(3002621) Streptococcal DNAse B [Units/volume] in Serum

118

293

2.79

21.76

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

4.65

21.75

1.3

1.2

—

(3045414) Leukocytes [Presence] in Urine

2582

14583

1.24

21.66

2.1

1.8

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

553

2433

1.58

21.59

1.3

1.2

u/ml

37.5

49.0

0.65

174

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

551

2429

1.58

21.34

1.3

1.2

u/ml

78.2

64.9

0.42

106

(3011985) Renin [Units/volume] in Plasma

904

4414

1.42

21.33

1.6

mu/l

67.4

65.1

0.12

799

3969

(3048689) Calprotectin [Mass/mass] in Stool

7099

43749

1.14

21.28

2.5

2.4

ug/g

163.2

127.0

8.55

5756

34359

(3012898) Urea [Moles/volume] in Urine

116

289

2.78

21.27

1.4

1.6

mmol/l

159.8

174.7

0.58

104

260

(3002523) Influenza virus A Ag [Presence] in Specimen

1136

5771

1.37

21.25

1.2

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4405

26218

1.18

21.17

2.4

2.2

nmol/l

12.0

12.6

5.64

3850

23476

(40768441) Liver Pathology biopsy report

527

2305

1.59

21.11

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

561

2496

1.56

20.89

1.3

1.2

u/ml

50.3

51.9

0.03

107

(3002619) Bacteria identified in Specimen by Culture

191

609

2.18

20.86

1.3

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1133

5773

1.37

20.81

1.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

521

2281

1.59

20.79

3.2

2.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

231

795

2.02

20.72

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

389

1582

1.71

20.69

7.3

5.7

u/ml

122.5

3844.7

1.07

103

303

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

150

433

2.40

20.59

7.6

7.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

392

1600

1.70

20.58

1.9

164.1

135.6

8.31

366

1513

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

539

2388

1.57

20.46

2.1

1.9

u/field

2.0

2.3

0.69

266

1047

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

185

590

2.18

20.22

1.3

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

207

691

2.08

20.16

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

207

691

2.08

20.16

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

207

691

2.08

20.16

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

207

691

2.08

20.16

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

217

740

2.03

19.98

1.1

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

4.23

19.86

5.7

5.8

mmol/l

16.8

17.6

0.35

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

39191

263230

1.09

19.83

4.3

3.9

pmol/l

14.8

14.7

15.27

35968

240689

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1308

6864

1.33

19.80

1.3

1.2

u/ml

43.4

42.0

0.11

154

639

(3032352) Blasts [#/volume] in Cerebral spinal fluid

117

305

2.66

19.76

2.1

2.9

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

549

2464

1.55

19.71

1.3

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

319

1248

1.77

19.46

8.7

9.8

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

572

2599

1.53

19.43

1.2

1.1

u/ml

74.3

58.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

528

2357

1.56

19.42

1.4

umol/l

13.7

11.7

7.45

493

2242

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

120

320

2.60

19.41

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

5.06

19.28

10.5

6.6

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

5.11

19.07

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

358

1457

1.71

19.05

1.6

1.4

3.2

4.7

1.34

311

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

143

419

2.37

19.04

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1989

11084

1.25

18.86

1.5

1.4

u/l

9.8

9.6

0.18

1583

9045

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

119

321

2.57

18.83

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

731

3523

1.44

18.59

3.3

3.2

nmol/l

7.3

6.9

0.08

706

3416

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

347

1413

1.70

18.45

2.1

ug/min

106.9

95.8

0.15

309

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

202

693

2.02

18.35

1.1

1.2

79.2

74.8

0.48

163

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

467

2055

1.58

18.32

2.9

2.8

ug/l

27.7

25.9

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

513

2309

1.54

18.23

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

113

302

2.59

18.23

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

202

696

2.01

18.14

1.2

92.6

86.8

0.76

170

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

319

1283

1.73

17.75

1.1

—

(40758292) HTLV I+II Ab panel - Serum

160

509

2.18

17.67

1.5

1.3

—

(40768443) Skin Pathology biopsy report

2467

14179

1.21

17.48

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

195

673

2.01

17.46

1.6

1.5

ug/l

0.4

0.41

134

439

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

118

330

2.48

17.40

1.3

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

5000

39201

0.87

17.35

1.5

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

179

3.06

17.16

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

494

2239

1.53

17.06

1.1

iu/ml

9.5

7.9

0.64

110

577

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

453

4747

0.66

16.75

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

728

3580

1.41

16.64

1.1

au/ml

26.8

22.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

131

394

2.31

16.54

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

4.45

16.44

1.0

1.2

ng/l

4272.3

2681.1

0.41

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

525

5324

0.68

16.42

1.4

1.3

ug/l

3.3

3.8

0.65

452

4768

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

713

3507

1.41

16.29

1.1

au/ml

51.7

70.6

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.93

15.97

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

289

1173

1.71

15.64

1.9

2.0

194.3

154.8

6.75

278

1109

(3001686) Cold agglutinin [Titer] in Serum or Plasma

151

494

2.12

15.63

1.4

1.3

titre

42.8

174.5

1.41

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

191

683

1.94

15.55

1.1

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

201

735

1.90

15.33

1.2

1.3

110.2

105.8

0.90

192

695

(3005011) Chlamydia sp Ab [Titer] in Serum

137

435

2.18

15.28

1.5

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

218

821

1.84

15.19

2.2

1.6

—

(3011288) Drugs identified in Urine by Screen method

1936

11021

1.22

15.13

4.9

2.9

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

597

2884

1.44

15.11

4.5

3.6

u/ml

61.2

45.1

1.06

592

2849

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

285

1164

1.70

15.10

2.9

2.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

488

2267

1.49

15.08

1.8

1.4

umol/l

67.2

70.4

0.47

187

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

104

3.60

15.06

1.9

1.5

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

133

420

2.20

15.04

1.2

1.5

nmol/l

66026.7

260064.5

1.13

103

348

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

807

4112

1.36

14.98

1.3

1.4

pmol/l

301.2

308.2

0.12

620

3222

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

5.44

14.95

3.9

4.0

—

(46236302) HLA-C [Type] by High resolution typing

3.68

14.94

1.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

46888

318493

1.09

14.92

22.7

10.6

ml/min/173m2

82.0

84.5

83.89

40255

259877

(3042517) Benzodiazepines panel - Urine

136

435

2.17

14.91

2.6

3.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

273

1106

1.71

14.91

1.1

87.6

92.5

0.95

143

508

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

132

418

2.19

14.83

2.5

mmol/l

1.3

1.4

0.33

300

(3019832) Treponema pallidum Ab [Presence] in Serum

5070

39316

0.88

14.73

1.7

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

155

3.04

14.70

1.1

u/field

1.2

1.3

0.36

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.37

14.68

3.6

3.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

220

841

1.81

14.64

1.3

1.2

g/l

38.5

40.7

1.24

129

445

(3045424) Erythrocytes [Presence] in Urine

1044

5545

1.31

14.64

1.6

1.4

—

(40763590) HLA-DQ beta [Type]

3.64

14.48

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1243

6765

1.28

14.47

4.7

3.0

mg/l

32.8

24.7

10.37

886

4094

(40760409) HLA-A [Type] by High resolution

3.61

14.29

1.0

—

(40760410) HLA-B [Type] by High resolution

3.61

14.29

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

139

457

2.11

14.26

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

246

981

1.74

14.23

1.3

1.2

27.9

18.4

1.05

159

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

280

1158

1.68

14.21

1.1

1.2

104.3

108.8

0.97

263

1040

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

257

2.51

14.15

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

510

2424

1.46

14.10

2.1

1.7

mmol/l

7.4

6.6

4.77

383

1778

(3013862) HLA-DP [Type]

3.57

14.09

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

127

405

2.17

14.06

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2418

14160

1.19

14.05

1.1

u/ml

18.5

7.4

0.46

221

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

5.62

14.02

1.0

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

198

2.73

14.00

1.2

ug/l

97.8

109.5

0.32

124

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

4.03

13.95

1.1

mmol/l

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

275

1138

1.68

13.93

1.1

87.6

91.4

1.01

143

518

(3019897) Erythrocyte distribution width [Ratio] by Automated count

541

5283

0.71

13.79

4.3

2.3

13.3

13.1

5.18

536

5214

(3000034) Microalbumin [Mass/volume] in Urine

567

2769

1.42

13.59

3.1

3.0

mg/l

92.8

45.6

2.10

431

1951

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

234

2.55

13.53

1.3

1.4

pmol/l

15.6

11.8

0.59

196

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

218

2.61

13.50

2.6

2.1

58.6

0.00

135

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.92

13.49

6.8

5.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

264

2.44

13.42

1.0

1.1

—

(3007463) Buprenorphine [Presence] in Urine

138

3.06

13.39

8.2

7.9

—

(3014051) Protein [Presence] in Urine by Test strip

1295

7158

1.26

13.31

2.5

2.0

—

(40763791) Oxygen content in Venous blood by calculation

4.00

13.21

5.0

8.3

ml/dl

12.0

12.9

0.57

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

925

4904

1.31

13.20

4.3

3.4

u/ml

41.3

36.4

0.43

899

4715

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

12131

78654

1.09

13.20

1.3

u/ml

1.7

0.25

3057

21602

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

8780

56131

1.10

13.17

2.7

2.9

ug/l

0.7

0.8

0.57

5832

35535

(3016244) Insulin [Units/volume] in Serum or Plasma

494

2367

1.45

13.14

3.4

3.2

mu/l

24.8

27.4

0.73

461

2222

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

3.76

13.10

1.0

—

(3005570) Glucose [Moles/volume] in Urine

619

3092

1.39

13.06

2.1

1.8

mmol/l

10.4

22.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

158

566

1.94

12.90

4.3

6.5

66.3

71.2

1.32

109

468

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

131

439

2.07

12.85

1.1

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

4.30

12.68

12.0

6.3

41.3

45.7

0.32

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

139

2.99

12.68

21.7

8.7

—

(3030313) Adrenal Ab [Titer] in Serum

104

319

2.26

12.68

1.2

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

5202

39931

0.89

12.64

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

256

1071

1.66

12.51

1.3

1.1

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

3.90

12.50

5.8

5.6

mg/l

1.1

1.5

0.71

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

871

4618

1.31

12.46

1.3

nmol/l

1.6

1.2

0.14

815

4475

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

296

2.30

12.39

2.1

2.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

248

2766

0.62

12.39

1.5

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

249

2.42

12.38

1.3

1.4

ml/s/173m2

0.9

1.8

1.97

162

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

286

3082

0.64

12.25

1.6

mmol/l

7.8

7.6

0.58

181

1832

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

867

4606

1.31

12.23

1.3

nmol/l

0.2

0.05

274

(3011335) Digoxin [Mass/volume] in Serum or Plasma

177

2.70

12.20

2.3

2.2

—

(36660697) Celiac disease serology panel - Serum

4549

28196

1.13

12.18

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

123

412

2.07

12.11

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

186

718

1.80

12.10

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

5.77

12.00

1.6

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

690

3561

1.35

11.92

1.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

53097

363331

1.10

11.88

28.6

13.1

umol/l

81.9

75.2

187.98

53077

363157

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

162

603

1.86

11.84

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2053

12047

1.19

11.71

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2163

12756

1.18

11.64

3.4

2.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

600

3042

1.37

11.63

2.2

2.3

nmol/l

18.5

19.6

1.52

559

2899

(4212803)

219

2.47

11.58

1.1

1.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

162

608

1.85

11.56

1.3

1.2

mg/l

77.1

41.8

0.34

118

440

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

789

4177

1.31

11.46

1.4

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

621

3185

1.35

11.21

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

151

563

1.86

11.02

2.6

2.4

mmol/l

7.9

7.3

0.97

336

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

183

733

1.73

10.58

1.2

pmol/l

388.6

309.3

0.41

132

549

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

45968

313072

1.07

10.57

5.2

4.6

mu/l

2.2

2.1

0.67

42518

289221

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

188

761

1.71

10.48

1.5

1.3

33.5

41.0

1.84

126

511

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

122

431

1.96

10.47

1.0

1.1

—

(3009992) Blasts/100 cells in Bone marrow

8.53

10.45

1.9

1.8

11.3

27.2

0.87

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

143

2.71

10.07

1.2

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

116

409

1.97

10.03

1.7

1.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

327

1529

1.48

10.00

1.5

1.6

mmol/24h

5.6

0.00

122

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

119

424

1.95

9.99

1.4

1.1

mmol/l

21.2

20.3

1.50

364

(3020618) Glucose [Moles/volume] in Synovial fluid

3.30

9.96

1.1

1.0

mmol/l

5.7

5.0

0.56

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

341

1611

1.47

9.91

1.1

1.2

u/ml

18.1

11.6

0.34

159

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1439

8310

1.20

9.87

1.7

1.9

iu/l

61.8

12.5

0.56

455

3143

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

325

1524

1.48

9.81

1.7

1.6

nmol/l

4.1

8.4

0.57

277

1261

(3001186) Copper [Moles/volume] in Serum or Plasma

199

834

1.65

9.79

1.5

1.3

umol/l

17.5

16.8

1.21

178

750

(3029075) Extractable nuclear Ab panel - Serum

229

997

1.59

9.69

1.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

299

2.11

9.53

2.4

2.2

umol/l

1.2

1.3

0.94

270

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.92

9.50

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2977

18256

1.14

9.49

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

44850

305565

1.06

9.31

6.5

5.3

mmol/mol

41.0

39.1

246.32

41702

284552

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

114

2.86

9.29

1.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

106

373

1.97

9.26

5.3

5.5

g/mol

37.6

211.7

0.75

342

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

155

2.55

9.12

1.2

1.3

u/l

1490.4

840.7

0.22

134

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

6.54

9.12

1.1

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

443

2231

1.38

9.08

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

720

6336

0.78

9.06

1.5

1.6

—

(3035933) Granulocytes/100 leukocytes in Blood

224

987

1.57

9.05

2.7

1.6

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

212

2.29

8.93

1.1

iu/ml

18.1

16.2

0.08

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

271

2.12

8.86

1.3

1.2

mg/l

48.9

47.8

0.07

(3022229) Phosphate [Moles/volume] in Urine

222

2.25

8.82

1.8

2.5

mmol/l

20.3

20.2

0.01

193

(3004446) Plasmodium sp identified in Blood by Light microscopy

100

351

1.97

8.82

2.7

2.5

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

115

424

1.88

8.80

1.2

1.4

43.1

54.3

1.44

206

(3003338) MCHC [Mass/volume]

42568

299741

0.94

8.64

32.4

14.5

g/l

331.2

333.1

293.27

42191

297562

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

100

354

1.96

8.62

2.1

2.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.32

8.58

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

313

2.02

8.50

1.1

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.09

8.37

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

3.92

8.25

1.0

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

496

2583

1.33

8.25

1.1

mg/l

299.6

403.0

0.43

454

2316

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

266

2.08

8.19

1.1

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

194

2.29

8.19

1.4

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

178

2.34

8.06

2.8

2.1

12.6

18.2

0.71

(3005082) Progesterone [Moles/volume] in Serum or Plasma

196

2082

0.65

8.05

1.3

1.4

nmol/l

29.3

31.6

0.57

172

1910

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

321

1.96

7.97

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

771

0.44

7.87

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

253

1184

1.48

7.83

1.3

1.4

pmol/l

16.5

14.4

1.79

217

991

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

420

2153

1.35

7.79

1.2

1.1

ratio

1.1

1.53

140

768

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

949

5398

1.22

7.72

1.1

iu/ml

49.4

2654.6

0.80

203

1218

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

186

822

1.57

7.51

1.3

nmol/l

132.9

128.3

0.13

127

616

(3042951) Complement C1q Ab [Units/volume] in Serum

142

2.44

7.41

1.2

1.3

u/ml

29.9

17.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

276

1332

1.44

7.33

1.1

ng/l

713.7

511.6

0.28

289

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.76

7.32

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1193

6974

1.19

7.29

1.8

1.6

—

(3018133) Calcium [Moles/volume] in Urine

144

604

1.65

7.21

2.2

2.3

mmol/l

2.4

2.7

0.79

128

550

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

111

2.62

7.19

1.2

1.1

—

(3028468) Fragments [Presence] in Blood by Light microscopy

7.56

7.17

2.4

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

144

606

1.65

7.12

1.5

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

167

730

1.59

7.10

1.5

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

167

2.28

7.07

1.3

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1274

7511

1.18

7.06

1.9

pmol/l

191.6

198.3

1.26

1205

7152

(37021550) Renin [Units/volume] in Plasma --upright

153

658

1.61

6.96

1.3

mu/l

143.2

64.4

0.92

116

497

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

319

1596

1.39

6.94

1.1

miu/ml

1518.2

1516.1

0.01

319

1596

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2082

12743

1.14

6.94

1.7

1.6

—

(44806071)

111

440

1.75

6.84

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

116

466

1.73

6.83

2.4

2.9

u/l

1943.2

1712.7

0.11

424

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

258

1248

1.43

6.81

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

267

1.97

6.80

1.1

1.0

u/ml

8.2

2.7

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

136

2.39

6.73

1.0

9.1

8.8

0.22

126

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

136

2.39

6.73

1.0

1.1

36.3

35.8

0.20

127

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

136

2.39

6.73

1.0

1.1

21.2

21.6

0.20

125

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

441

2332

1.31

6.69

1.4

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

438

2316

1.31

6.66

1.4

1.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

133

560

1.65

6.60

4.5

4.9

u/l

50.8

57.6

0.24

217

(3006270) Folate [Moles/volume] in Blood

483

2596

1.29

6.51

1.2

1.1

nmol/l

340.6

376.3

2.80

395

2229

(3023323) Follitropin [Units/volume] in Serum or Plasma

2363

18251

0.89

6.45

1.4

iu/l

24.6

26.9

2.98

1972

15696

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

4.11

6.44

1.2

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

149

652

1.58

6.36

2.2

2.6

—

(3024869) Neuronal Ab [Presence] in Serum

129

545

1.64

6.34

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

232

1117

1.44

6.32

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

199

931

1.48

6.28

1.5

1.4

60.9

52.7

2.36

166

799

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

591

5085

0.80

6.27

1.3

mmol/l

7.3

7.0

1.53

432

3639

(4094501)

1119

9059

0.85

6.17

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

147

2.26

6.10

1.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

147

2.26

6.10

1.0

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

257

1271

1.40

6.05

2.2

2.7

ug/l

1.2

0.06

242

1197

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

404

2143

1.31

6.05

3.6

3.2

nmol/l

154.0

122.1

0.98

395

2107

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

114

2.43

5.96

10.4

8.9

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

220

1.98

5.79

1.0

1.2

29.8

18.6

0.51

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

963

7840

0.85

5.73

1.5

1.4

pmol/l

148.1

124.3

0.82

937

7644

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

361

1901

1.32

5.73

1.1

nmol/l

5.2

5.0

0.03

358

(3046914) Granular casts [#/area] in Urine by Computer assisted method

3.31

5.63

1.3

1.4

u/field

0.7

0.15

(4024509)

519

2870

1.25

5.63

1.6

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

252

1.90

5.60

5.5

2.6

16.2

9.5

1.60

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

178

1780

0.69

5.53

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

205

1.99

5.52

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

205

1.99

5.52

3.9

4.9

—

(3019174) dRVVT (LA screen)

288

1.83

5.52

1.2

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

106

2.42

5.48

1.1

u/field

1.0

1.3

0.50

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

184

2.03

5.34

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

232

1.91

5.33

1.3

1.2

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

199

1.98

5.28

1.3

1.5

12.2

13.1

0.10

141

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

228

1.91

5.28

1.3

1.5

45.5

35.6

1.08

149

(3013293) Extractable nuclear Ab [Presence] in Serum

111

477

1.61

5.19

1.7

1.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

144

658

1.52

5.17

1.1

umol/24h

0.7

3.0

0.54

325

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

485

2691

1.25

5.15

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

183

2.01

5.08

1.7

0.7

0.04

141

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

169

2.05

5.07

1.2

1.4

3.3

0.9

1.50

109

(37019676) Renin [Units/volume] in Plasma --supine

2.84

5.03

1.0

1.1

mu/l

77.8

48.0

0.30

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

175

2.02

4.98

1.1

u/l

2.4

3.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

288

1502

1.33

4.96

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

100

424

1.63

4.95

1.1

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

350

1877

1.29

4.93

1.6

1.5

ug/l

10.9

7.5

1.11

312

1706

(3001729) Color of Synovial fluid

219

1.90

4.93

1.6

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

121

2.23

4.89

1.0

u/ml

0.1

0.32

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2564

19409

0.91

4.82

1.1

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

5.77

4.80

1.0

1.2

—

(3021374) Sirolimus [Mass/volume] in Blood

3.69

4.78

12.1

7.4

ug/l

6.9

7.4

0.33

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

382

1.65

4.71

2.5

2.3

u/field

0.6

0.14

382

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

380

2074

1.27

4.69

2.1

1.9

—

(3024316) Viscosity of Plasma

142

2.10

4.66

2.1

1.7

mpas

1.6

1.7

0.50

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

3.08

4.61

1.1

1.0

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.48

4.57

1.6

1.5

nmol/l

400.0

186.6

0.97

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

242

1247

1.35

4.56

2.1

2.0

mg/l

8.1

9.5

3.47

199

990

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

116

2.21

4.55

1.2

1.3

u/field

1.1

1.2

0.13

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.88

4.55

1.5

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

139

2.09

4.53

1.0

u/ml

0.1

0.2

0.70

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

204

1025

1.38

4.51

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

197

1.90

4.48

1.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

3.01

4.46

5.7

7.3

e6/l

6666.2

442.3

0.44

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3346

21498

1.08

4.45

1.3

au/ml

36.7

50.2

2.66

910

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

368

1.64

4.40

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

160

1555

0.71

4.33

1.6

1.4

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

198

998

1.38

4.31

1.7

au/ml

80.2

145.1

1.85

124

(3044009) aPTT.lupus sensitive (LA screen)

307

1.69

4.30

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

3.73

4.24

1.1

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

351

1923

1.27

4.24

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

217

1.82

4.18

1.1

u/l

11.4

9.2

0.44

217

(3016879) Cocaine [Presence] in Urine

2433

15469

1.09

4.17

3.3

2.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

134

636

1.46

4.10

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

226

1174

1.33

4.09

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

288

0.36

4.08

1.1

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

184

1.88

4.08

1.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

376

1.60

4.07

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

107

486

1.53

4.05

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

200

1.84

4.01

1.3

pmol/l

15.3

17.3

0.47

172

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

100

2.22

4.00

1.1

pmol/l

185.5

214.3

0.15

(4146454)

566

3290

1.19

3.92

2.7

2.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

247

1311

1.31

3.87

1.2

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

178

1.87

3.85

1.2

1.1

u/l

65.5

88.0

0.20

144

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

355

3042

0.81

3.82

1.4

1.3

pmol/l

87.5

111.6

0.33

168

909

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.53

3.81

1.7

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

289

1572

1.27

3.76

1.1

97.1

97.4

0.07

249

1239

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

484

2790

1.20

3.70

1.1

mg/l

304.2

262.3

1.32

426

2448

(3009015) Lactate [Moles/volume] in Synovial fluid

305

1.64

3.69

1.2

1.3

mmol/l

6.2

6.0

0.07

149

(4034850)

1684

10591

1.10

3.68

13.1

8.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3625

23543

1.07

3.66

2.4

au/ml

24.6

23.2

0.24

145

1504

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

376

1.57

3.66

3.4

3.0

mg/l

18.7

23.5

3.08

356

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

280

1.66

3.62

1.3

1.2

nmol/l

16.9

16.4

0.08

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

4.33

3.62

1.1

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

438

1.52

3.61

14.0

6.0

—

(40761511) CBC panel - Blood by Automated count

52202

359181

1.05

3.61

23.1

10.8

—

(3007916) DNA double strand Ab [Titer] in Serum

407

1.53

3.53

1.6

1.3

titre

271.4

116.9

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

2.38

3.52

1.8

1.5

nmol/l

464.2

211.7

0.80

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

369

1.56

3.51

3.4

3.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

225

1197

1.30

3.51

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.20

3.49

1.4

1.1

—

(3025130) Human papilloma virus identified in Specimen

627

5055

0.86

3.49

1.7

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

340

1904

1.24

3.48

1.0

ng/l

268.2

342.1

2.77

245

1362

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

116

2.03

3.47

1.4

nmol/l

682.6

445.7

1.20

116

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

5.67

3.44

1.1

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

5.67

3.44

1.1

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.57

3.43

1.1

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

2.34

3.43

2.1

1.5

umol/l

246.2

304.0

0.25

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

729

5804

0.87

3.42

1.5

1.4

nmol/l

0.4

0.66

545

4578

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

497

2895

1.19

3.42

1.2

1.1

mg/l

50.2

42.0

0.95

419

2418

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2083

15645

0.92

3.39

2.5

2.3

u/l

5267.0

6065.6

0.54

729

6149

(3041184) Isoniazid [Presence] in Urine

3.13

3.35

2.9

2.5

—

(3017509) Phencyclidine [Presence] in Urine

436

1.49

3.31

2.1

1.9

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

149

754

1.37

3.28

1.1

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

321

1.58

3.27

1.1

umol/24h

1.8

2.8

0.46

321

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

271

2345

0.80

3.26

1.2

1.3

g/l

1.4

1.5

0.55

129

(4027681)

390

2234

1.21

3.24

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

210

1.72

3.22

1.3

1.4

umol/24h

354.6

320.7

0.38

210

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

12849

86451

1.04

3.21

1.7

1.6

mmol/l

1.5

1.4

39.42

11026

72977

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

339

1918

1.23

3.19

1.0

ng/l

740.2

748.9

0.13

229

1329

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

243

1324

1.27

3.19

1.2

1.3

—

(3015183) Erythrocyte sedimentation rate

217

1920

0.78

3.18

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

339

1922

1.22

3.14

1.0

ng/l

40.7

41.9

0.07

236

1354

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

3.11

3.09

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

207

1111

1.29

3.08

1.1

—

(3000285) Sodium [Moles/volume] in Blood

371

1.51

3.06

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

137

1.87

3.05

3.0

2.5

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

105

1.98

2.91

1.3

1.1

nmol/l

321.1

249.1

0.69

105

(3043614) Bacteria identified in Aspirate by Culture

6.06

2.89

1.0

1.1

—

(3017400) Magnesium [Moles/volume] in Urine

2.18

2.85

1.2

1.3

mmol/l

3.3

3.2

0.07

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

46628

325349

0.97

2.83

4.9

4.2

mmol/l

6.1

5.9

179.59

42776

299653

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

152

1.78

2.77

1.2

1.3

—

14622.3

—

(3022689) Creatine [Moles/volume] in Urine

171

912

1.30

2.72

1.7

1.4

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

211

1157

1.26

2.70

1.3

1.2

112.8

110.8

0.46

185

1041

(3035082) Kappa light chains [Mass/volume] in Urine

2.20

2.68

1.2

1.0

g/l

0.5

0.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

104

516

1.40

2.65

1.5

1.8

pmol/l

46.5

57.8

0.46

429

(3027974) Hepatitis B virus e Ag [Presence] in Serum

207

1.64

2.64

1.6

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

273

1.55

2.61

1.0

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

382

1.45

2.53

1.7

1.8

mg/l

1.6

1.7

0.26

323

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

647

5067

0.88

2.49

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

334

1941

1.19

2.48

1.1

u/l

1.1

0.98

141

882

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1695

10880

1.08

2.48

1.8

1.7

nmol/l

39.2

40.8

1.90

1651

10636

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

108

1.86

2.41

1.8

2.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

433

1.41

2.39

2.7

2.6

pmol/l

69.1

69.2

0.00

374

(3017501) Neutrophils [#/volume] in Blood by Manual count

6.93

2.33

1.6

1.2

—

(3006969) Lambda light chains [Mass/volume] in Urine

2.16

2.33

1.1

1.0

g/l

0.0

0.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

189

1.61

2.27

1.1

—

(3051339) Copper [Moles/volume] in Blood

168

1.65

2.25

1.3

umol/l

16.4

16.6

0.11

144

(3000764) Benzodiazepines [Presence] in Urine

2546

16640

1.06

2.25

3.3

2.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.93

2.24

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

4.04

2.19

1.0

1.2

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.04

2.19

1.0

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

3154

22968

0.95

2.17

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

204

1729

0.82

2.16

1.8

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.99

2.14

1.5

1.6

ug/l

135.1

127.7

0.04

(3028300) Cannabinoids [Presence] in Urine

2563

16787

1.06

2.13

3.3

2.0

—

(40760083) Phosphate/Creatinine [Ratio] in Urine

5.77

2.12

4.2

3.3

—

(3025577) Chromium [Mass/volume] in Blood

294

1718

1.19

2.12

1.9

2.1

ug/l

2.3

0.06

234

1451

(3027874) Urate [Moles/volume] in Urine

1.84

2.11

1.2

1.0

mmol/l

1.6

8.1

0.52

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.22

2.11

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

158

867

1.26

2.10

1.6

1.3

—

(3027008) Opiates [Presence] in Urine

2554

16743

1.06

2.06

3.2

2.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

257

0.54

2.05

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

301

1770

1.18

2.03

1.9

2.0

ug/l

3.5

3.6

0.07

260

1559

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

262

1.48

2.03

1.3

1.4

u/ml

6.3

6.8

0.04

219

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

168

935

1.25

2.00

1.6

ug/l

10.0

9.0

1.77

168

935

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

152

839

1.26

1.95

1.1

—

(3013762) Body weight Measured

127

1.69

1.94

1.2

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

141

0.44

1.88

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

134

1.65

1.87

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

194

1.54

1.86

1.2

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

229

0.54

1.82

1.2

1.1

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

4.33

1.77

1.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

4.33

1.77

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

455

0.68

1.75

1.2

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

375

2277

1.14

1.71

1.1

1.2

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

3.46

1.71

1.0

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

217

1263

1.19

1.71

1.3

1.2

g/l

0.3

1.41

175

1005

(40762814) Titanium [Mass/volume] in Blood

487

1.31

1.68

2.3

ug/l

3.6

3.7

0.02

170

(3013945) Hepatitis B virus e Ab [Presence] in Serum

205

1.49

1.68

1.6

1.4

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.82

1.64

1.0

1.4

—

(3011048) Pyruvate [Moles/volume] in Blood

235

1.44

1.63

1.3

1.4

umol/l

89.9

81.0

0.64

216

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

103

1.68

1.58

1.0

u/ml

0.0

0.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

2.19

1.57

1.1

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

2.19

1.57

1.1

1.3

—

(40768793) Breast Pathology biopsy report

981

7322

0.93

1.56

1.4

1.3

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

142

802

1.23

1.55

1.1

mg/g

7.6

6.9

0.44

133

764

(36303858) Crystals [Presence] in Urine

2.09

1.54

1.2

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.60

1.52

1.1

1.0

—

(3049233) Organic acids panel - Urine

1.78

1.52

1.3

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

275

1652

1.15

1.51

1.1

u/ml

8.8

9.7

0.17

282

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

245

1.41

1.50

1.0

1.1

u/ml

26.7

24.5

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

245

1.41

1.50

1.0

1.1

u/ml

40.0

31.8

0.19

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

3.46

1.49

2.6

2.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

10326

70055

1.03

1.49

1.6

—

(4281824)

537

3368

1.11

1.47

1.2

1.1

—

(3032641) Amino acids panel - Urine

1.88

1.45

1.5

1.2

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.18

1.43

3.1

2.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

156

1291

0.84

1.41

1.0

—

(3027944) Amphetamines [Presence] in Urine

2486

16486

1.05

1.39

3.0

1.9

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.89

1.38

1.1

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

315

1.34

1.37

1.0

kpa

3.6

0.00

270

(3006462) Nitrate [Presence] in Urine

262

1582

1.15

1.37

3.3

2.9

—

(3003694) ABO and Rh group [Type] in Blood

14464

98625

1.02

1.33

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

521

3286

1.10

1.31

1.3

1.4

mmol/l

12.1

11.8

0.24

208

735

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

241

1456

1.15

1.27

3.0

3.4

mg/l

8.2

8.1

0.10

186

1171

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

221

1327

1.15

1.27

2.5

2.8

au/ml

145.0

154.2

0.10

166

(3006567) Chloride [Moles/time] in 24 hour Urine

1.82

1.26

1.1

1.2

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

162

1.45

1.23

1.5

1.7

ng/l

198.2

201.3

0.07

141

(1617658) Protocol used for examination of sentinel lymph nodes

307

2386

0.89

1.22

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

322

1.31

1.22

1.0

mmol/l

-1.3

-2.3

0.52

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.00

1.20

1.2

1.1

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

323

1.31

1.19

1.0

kpa

7.4

7.2

0.28

279

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.66

1.18

1.2

1.1

—

(3006598) pH of Arterial cord blood

324

1.30

1.17

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

124

1025

0.84

1.16

2.8

3.2

—

(3036180) Methadone [Presence] in Urine

1.65

1.16

1.7

3.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

124

1024

0.84

1.15

5.7

6.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3457

24710

0.97

1.13

1.2

iu/ml

128.1

143.5

1.45

1168

9416

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

113

650

1.20

1.12

1.5

nmol/l

0.2

1.00

477

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

191

1150

1.15

1.10

1.0

—

(3034614) HLA Ag [Interpretation]

1.64

1.10

1.4

1.2

—

(4211845)

281

1736

1.12

1.09

3.3

2.8

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

132

1.47

1.09

1.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

1.76

1.09

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

5859

39652

1.03

1.07

11.0

6.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.62

1.05

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1537

10165

1.05

1.04

1.1

u/ml

7.5

5.3

0.69

150

1380

(3036005) Urine sediment comments by Light microscopy Narrative

1.95

1.03

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

2.31

1.01

1.0

1.1

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

2.31

1.01

4.2

5.5

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

2.31

1.01

1.0

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

207

1.34

0.96

1.0

u/ml

1.0

0.5

0.49

187

(3010937) Rubella virus Ab [Presence] in Serum

207

1.34

0.96

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

182

1431

0.88

0.94

1.8

1.9

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

238

1.31

0.94

1.0

1.1

u/ml

1.2

1.5

0.19

173

(3021387) Prolactin [Units/volume] in Serum or Plasma

2067

13798

1.04

0.94

1.7

1.6

mu/l

336.3

308.8

2.01

1859

12476

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.82

0.87

1.0

1.1

—

(44806420)

130

779

1.16

0.86

2.1

2.4

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

146

1.38

0.84

1.6

1.5

u/l

0.2

0.09

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

274

1.26

0.83

1.1

—

(3008898) HLA-B27 [Presence]

1755

12597

0.96

0.80

1.1

—

(44813793)

411

2641

1.08

0.78

1.1

—

(4133840)

161

988

1.13

0.78

1.3

1.2

—

(3049242) von Willebrand panel - Platelet poor plasma

102

1.43

0.75

1.4

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

888

5859

1.05

0.74

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

256

1941

0.91

0.74

1.3

—

(3003157) Bacteria [#/volume] in Mother's milk

0.55

0.74

5.0

6.9

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

138

1.36

0.74

1.2

1.1

u/l

304.5

358.3

0.17

119

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.53

0.73

1.3

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

501

1.18

0.72

1.1

u/ml

0.3

0.14

302

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.80

0.72

1.0

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

52876

365390

1.02

0.72

15.3

9.1

u/l

27.4

26.7

5.42

51562

352959

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.45

0.71

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.69

0.71

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.69

0.71

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.69

0.71

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.69

0.71

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.69

0.71

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.69

0.71

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

281

2116

0.92

0.71

2.4

1.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1774

11891

1.03

0.70

1.3

miu/ml

211.4

224.4

0.71

642

5662

(3021367) Citalopram [Moles/volume] in Serum or Plasma

1.51

0.70

1.5

1.4

nmol/l

164.7

129.4

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

1.92

0.70

1.0

1.1

umol/l

64.6

20.9

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

472

1.17

0.69

2.2

2.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

208

1.27

0.67

1.2

1.1

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

1.82

0.66

1.4

1.0

—

(40768800) Prostate Pathology biopsy report

799

5791

0.95

0.63

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

216

1.25

0.63

1.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

1.73

0.63

1.0

1.1

umol/l

12.6

17.3

—

(3034707) Cochineal extract IgE Ab [Units/volume] in Serum

0.00

0.62

0.0

1.1

—

0.7

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.39

0.61

1.1

1.0

—

(3022670) pH of Venous cord blood

108

1.35

0.58

1.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

585

1.14

0.57

1.6

1.5

nmol/l

5.1

6.1

0.73

562

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

1.66

0.56

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

635

0.87

0.56

1.5

1.8

ug/l

2.4

3.5

0.49

382

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

544

0.87

0.54

1.1

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

510

1.14

0.54

5.5

5.7

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.54

0.53

1.0

1.1

titre

1112.0

2208.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

444

0.86

0.50

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.33

0.50

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

187

0.78

0.49

1.0

—

(3025966) Peach IgE Ab [Units/volume] in Serum

1.56

0.49

1.1

1.0

u/ml

2.7

3.5

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

1.51

0.49

1.0

—

(42870560) Thyrotropin [Units/volume] in Cord blood

385

1.15

0.48

1.0

mu/l

10.0

8.5

0.98

327

(3014599) Egg white IgE Ab [Units/volume] in Serum

328

2409

0.94

0.48

1.1

u/ml

5.7

5.1

0.08

111

654

(3015076) Soybean IgE Ab [Units/volume] in Serum

291

2145

0.94

0.48

1.1

1.0

u/ml

0.7

0.8

0.08

311

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

155

0.76

0.48

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

276

1.18

0.47

1.0

u/ml

2.1

1.4

0.24

190

(3012989) Citrate [Moles/time] in 24 hour Urine

1.39

0.47

1.1

1.5

mmol/24h

1.6

2.1

0.66

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.66

0.46

3.9

5.6

mmol/l

0.2

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

511

1.13

0.46

1.1

1.0

ug/l

77.7

82.7

0.46

425

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

239

1.19

0.45

3.2

2.9

pmol/l

1270.2

77.5

0.47

(3020874) Milk IgE Ab [Units/volume] in Serum

337

2465

0.95

0.44

1.1

u/ml

2.3

2.4

0.01

120

776

(3009542) Hematocrit [Volume Fraction] of Blood

46478

321205

1.01

0.42

27.0

12.2

39.0

40.2

150.52

32822

242851

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

311

2040

1.06

0.41

1.4

1.3

umol/l

4.4

5.0

2.41

280

1880

(3032868) Hemoglobin electrophoresis panel in Blood

326

1.15

0.41

1.6

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.35

0.41

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

444

3209

0.96

0.39

4.4

4.7

u/ml

106.6

0.00

111

1003

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

134

0.78

0.38

1.0

u/ml

0.9

0.2

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

232

1.16

0.37

1.1

u/ml

2.9

1.9

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

175

1.19

0.35

1.3

1.2

—

(4038314)

304

0.87

0.35

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

436

0.89

0.35

5.8

1.2

mmol/l

8.6

6.9

2.56

136

(3023430) Cat dander IgE Ab [Units/volume] in Serum

730

5211

0.97

0.34

1.1

u/ml

4.6

5.5

0.68

364

2174

(3001556) Androgen free Index in Serum or Plasma

399

1.11

0.32

1.5

1.3

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

115

0.78

0.32

1.0

u/ml

1.2

0.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

629

4490

0.97

0.31

1.1

1.0

u/ml

0.3

0.5

0.62

199

957

(3014133) Dog dander IgE Ab [Units/volume] in Serum

779

5543

0.97

0.31

1.1

u/ml

5.4

4.5

0.45

372

2196

(3011897) Casein IgE Ab [Units/volume] in Serum

108

693

1.08

0.31

1.2

1.3

u/ml

1.7

6.6

1.23

167

(3034274) Bile acid [Moles/volume] in Serum --fasting

713

5074

0.97

0.30

2.1

2.2

umol/l

6.6

7.1

0.39

534

3695

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

753

5354

0.97

0.29

1.1

u/ml

3.4

2.9

0.33

292

2655

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2481

17426

0.99

0.29

3.6

3.2

u/ml

58.3

49.8

0.66

2397

16824

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.20

0.26

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

274

1975

0.96

0.26

1.3

1.4

mmol/l

5.8

5.6

2.21

252

1872

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

126

0.82

0.25

1.0

u/ml

1.7

0.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

964

6542

1.02

0.25

1.1

u/ml

2.7

2.3

0.30

281

1631

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

420

1.09

0.25

1.1

u/ml

4.1

2.9

0.24

328

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

112

729

1.06

0.24

1.2

1.1

u/ml

7.8

7.3

0.05

521

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

114

837

0.94

0.23

2.2

2.6

ng/l

112.8

111.8

0.02

461

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.75

0.23

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.24

0.22

4.2

3.7

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.3

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.22

0.0

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

414

0.92

0.22

1.1

1.0

u/ml

10.3

1.6

0.43

224

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

191

1.12

0.21

1.1

1.0

u/ml

0.7

10.2

0.48

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

585

0.94

0.21

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

262

0.90

0.21

1.0

u/ml

0.1

0.9

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.20

0.0

1.3

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

418

1.08

0.20

1.1

u/ml

2.4

5.4

0.83

324

(3025886) Oxalate [Mass/time] in 24 hour Urine

100

1.18

0.20

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1928

13511

0.99

0.20

1.9

1.8

—

(40758358) Immune stain study

140

1.14

0.19

1.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

393

1.08

0.19

1.0

u/ml

0.2

0.19

241

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

225

1505

1.04

0.19

1.2

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

833

5674

1.02

0.18

1.3

1.4

u/l

24.5

25.6

0.50

683

4683

(40762887) Creatinine [Moles/volume] in Blood

1.20

0.17

1.3

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

408

0.93

0.17

1.1

1.0

u/ml

1.9

0.5

0.39

222

(3001218) Citrate [Mass/time] in 24 hour Urine

1.13

0.16

1.0

1.4

—

(3003577) Lead [Moles/volume] in Blood

276

1.08

0.15

1.5

1.4

umol/l

0.2

0.03

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

170

1138

1.03

0.15

1.1

1.0

u/ml

8.5

10.8

0.55

150

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

696

4745

1.02

0.15

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2493

17400

0.99

0.14

1.1

titre

114.3

217.8

2.71

469

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

518

0.95

0.14

1.2

1.1

—

(1002224) Polysomnography panel

2156

15053

0.99

0.14

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

244

1.08

0.14

1.0

u/ml

0.8

1.3

0.35

182

(3012494) Peanut IgE Ab [Units/volume] in Serum

166

1186

0.97

0.13

1.1

u/ml

2.5

16.0

0.95

105

701

(3022475) Manganese [Moles/volume] in Blood

218

0.92

0.13

1.2

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

672

4592

1.01

0.12

1.6

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

390

2749

0.98

0.12

1.7

1.4

g/l

0.9

0.59

385

2729

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

443

1.05

0.11

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

336

1.05

0.10

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

328

2234

1.02

0.10

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

150

1064

0.98

0.09

2.8

3.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

365

1.04

0.08

1.1

1.0

u/ml

0.2

0.5

1.07

200

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

106

755

0.97

0.08

1.9

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.79

0.08

1.2

1.1

mmol/24h

147.9

144.2

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.85

0.08

1.0

38.8

34.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1117

7789

0.99

0.07

1.4

1.3

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

227

0.95

0.07

1.0

u/ml

10.8

20.0

1.60

187

(3044336) Cobalt [Moles/volume] in Urine

0.89

0.07

2.7

2.4

nmol/l

10.6

28.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.14

0.07

1.1

nmol/24h

68.9

107.6

—

(3033942) Copper [Moles/time] in 24 hour Urine

169

1.07

0.07

1.3

1.2

umol/24h

1.5

0.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1129

7770

1.01

0.07

1.1

u/ml

2.4

1.6

0.97

547

3210

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

196

1380

0.98

0.07

1.3

1.4

72.6

72.9

0.10

181

1317

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.84

0.07

2.0

2.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

102

1.09

0.06

1.6

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

144

1014

0.98

0.05

1.3

1.4

—

(3007700) Barley IgE Ab [Units/volume] in Serum

175

0.95

0.05

1.0

u/ml

0.3

8.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

226

1.04

0.05

1.1

—

(3020650) Glucose [Presence] in Urine

138

941

1.02

0.05

1.6

1.4

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

193

1353

0.99

0.04

1.3

1.4

mu/l

590.4

697.7

0.46

178

1290

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

411

0.98

0.03

1.1

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1459

10129

1.00

0.03

1.9

1.8

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

112

1.05

0.02

1.1

1.0

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

257

1.02

0.02

1.1

u/ml

6.9

9.1

0.35

165

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5699

39440

1.00

0.02

4.5

4.3

31.9

32.1

0.99

4201

27377

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

285

1.02

0.01

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1016

7023

1.00

0.01

1.1

u/ml

5.8

5.5

0.19

601

3664

(3008401) Mugwort IgE Ab [Units/volume] in Serum

964

6689

1.00

0.01

1.1

u/ml

1.1

0.02

482

2883

(3017958) Strawberry IgE Ab [Units/volume] in Serum

113

1.04

0.01

1.0

u/ml

0.1

0.2

0.17

(3016031) Almond IgE Ab [Units/volume] in Serum

279

1.02

0.01

1.0

1.1

u/ml

0.8

0.9

0.17

170

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.02

0.00

1.0

u/ml

0.2

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

0.98

0.00

1.1

1.4

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.04

0.00

1.7

2.5

mu/l

2.9

2.3

0.14

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.03

0.00

1.0

u/ml

0.1

0.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

293

2033

1.00

0.00

5.9

6.7

—

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

0.96

0.00

1.2

1.1

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.97

0.00

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.90

0.00

1.0

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.89

0.00

1.0

1.1

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.94

0.00

1.6

1.0

2.7

2.5

—

(3040794) Aluminum [Moles/volume] in Urine

1.01

0.00

1.3

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: PNEUMONIA – Pneumonias (Asthma/COPD co-morbidities)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Pneumonias (Asthma/COPD co-morbidities)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints